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1. Introduction
The maintenance of glucose levels represents one of the most tightly regulated systems in the
body. All cells require glucose, however, it is only available from exogenous sources or hepatic
production. Since glucose cannot be stored in significant amounts except as glycogen in the
liver and muscle, glucose transport into the cell by specific transport proteins is critical for cell
function. Insulin plays a major role in the maintenance of normal glucose levels. When blood
glucose levels rise, insulin secretion is stimulated, resulting in increase in uptake of glucose by
skeletal muscle via glucose transporter protein 4 (GLUT4), and decreased production by the
liver. Binding of insulin to its receptor leads to activation of insulin receptor tyrosine kinase,
which phosphorylates IRS proteins that function as docking platforms for the two main
signalingpathways are responsible downstream regulation [1]; the phosphatidyl inositol 3-
kinase (PI3K)-Akt/protein kinase B (PKB) pathway and the Ras-mitogen-activated protein
kinase (MAPK) pathway. There appear to be several key proteins in the insulin/glucose and
protein turnover regulatory cascade, including IRS-1 the predominent form of IRS in muscle.
When levels of insulin and glucose are abnormally high in the fasting state, a condition called
insulin resistance exists. Insulin resistance and muscle wasting during the persistent high
grade inflammation induced by severe burn injury increases the patients risk for infection,
sepsis, and death. Clinical data indicate that a resting metabolic rate switch occurs after burn
injuries that involve ~40-60% total body surface area (TBSA). Based on studies of 189 pediatric
burn patients [2,3,4], it was determined that burn size determines the inflammatory and
hypermetabolic response to injury; serum glucose and insulin levels increased to 144 mg/dl
and 32 ng/ml on day 8 after injury. Metabolic alterations such as abnormal cytokine release [5,
6], altered gene expression [7,8] and increased protein catabolism are common in patients with
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burn injuries [9,10,11]. Glucose intolerance and elevated insulin levels may contribute to
hyperglycemia, even in non-diabetic patients [12,13,14,15,16,17]. Hyperglycemia and glucose
intolerance are frequently associated with the metabolic response to major trauma. Following
injury [18], burn shock [19,20] or systemic infection [21,22], oral and intravenous glucose
tolerance tests have demonstrated delayed disposal of glucose from plasma into tissues. This
“diabetes of injury” could be explained if there was an insulin deficiency, and several studies
[23] have shown that early after trauma (“ebb phase”) insulin concentrations are reduced even
in the face of hyperglycemia. After resuscitation of trauma patients (“flow phase”), beta cell
responsiveness to glucose administration and plasma insulin levels are appropriate or even
higher than expected. However, despite this appropriate acute insulin response to glucose
administration, glucose intolerance and hyperglycemia continue. This finding suggests that
some of the tissues in trauma patients are relatively insensitive to the effects of insulin.
There are numerous reports that describe insulin resistance in burn patients and animal models
[24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39]. Direct measurements show that liver and
skeletal muscle are resistant tissues. In addition, lipolysis is not attenuated in trauma patients
after glucose administration. The precise mechanism for insulin resistance after burns or other
stressors is unknown. It is likely, however, that insulin binding to its membrane receptors is
normal, and that there is a post receptor mechanism for the insulin resistance. Alterations in
levels of cytokines, such as TNF, IL-1, and IL-6, have been reported in burn patients and animal
models of burn injury by our laboratory and other investigators [38]. Infusion of endotoxin,
TNF, and IL-1 can produce alterations in glucose metabolism and insulin resistance in vivo [40,
41]. In addition, it has also been shown that endotoxin [42] and IL-6 [43] can produce insulin
resistance in isolated hepatocyte cultures and that IL-6 inhibits insulin mediated stimulation
of glucokinase in isolated hepatocytes. Cortisol, glucagon and epinephrine, can produce
insulin resistance [44]. These molecules oppose the actions of insulin and are termed counter-
regulatory hormones. Since these counter-regulatory hormones are elevated, at least initially,
after burn injury, it has been proposed that counter-regulatory hormones may play a role in
burn induced insulin resistance. The levels of cytokines and counter-regulatory hormones are
dramatically altered in burn patients and animal models [45,46]. It has been demonstrated that
TNF suppresses insulin-induced tyrosine phosphorylation of insulin receptor, and inhibits
downstream signaling from the insulin receptor [47,48]. Furthermore, the insulin resistance
produced in spontaneously obese rats can be overcome by pretreatment of the animals with
antibodies to TNF [49].
Although the number of investigations that address the mechanism(s) of insulin resistance in
trauma patients has been limited, one important study [50] using the euglycemic insulin clamp
technique demonstrated: (i) the maximal rate of glucose disposal is reduced in trauma patients;
(ii) the metabolic clearance rate of insulin is almost twice normal in these patients; and (iii)
post-trauma insulin resistance appears to occur in peripheral tissues, probably skeletal muscle,
and is consistent with a post-receptor effect. Unfortunately, the procedures used in this study
were not capable of independently accessing the contributions of glucose transport, phos‐
phorylation, and subsequent intracellular metabolism of glucose. Ikezyet al [51] demonstrated
that burn injury to rats resulted in impaired insulin-stimulated transport of [3H]-2-deoxyglu‐
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cose into soleus muscle strips in vitro. These investigators also demonstrated that insulin
stimulated phosphoinositide 3-kinase (PI3K) activity, that is pivotal for glucose transport in
muscle by GLUT 4, was decreased by burn injury to rats as measured by its IRS-1 associated
activity. These data are consistent with alterations in post-receptor signaling following burn
injury, which results in burn induced insulin resistance and muscle wasting.
Dynamic and stress dependent multi-site phosphorylations of IRS-1 tyrosine, serine and
threonine residues have been described to have both positive and negative insulin effects. IRS
proteins contain a conversed pleckstrin homology (PH) domain located at their N termini and
that anchors them to membrane phosphoinositides in close proximity to the insulin receptor.
The PH domain is flanked by a phosphotyrosine-binding (PTB) domain.
PhosporylatedSer/The residues in the PTB proximity are likely to dissociate IRS-IR binding
and weaken insulin signaling. Tyrosine phosphorylations, in the N- or C-terminal regions of
IRS-1 are generally considered to be positive PTM in the insulin signaling pathways. In other
words, IRS-1 binds several Src homology 2 domain (SH2) proteins through its multiple tyrosine
phosphorylation sites with YMXM or YXXM motifs to propagate the signal. In contrast,
phosphorylations of serine and threonine residues at the C-terminal region are usually
considered to be negative PTMs, however, some positive effects of serine phosphorylations
have been reported. A number of phosphorylation sites have been identified with different
approaches such as: radiolabeling with [γ- 32p] ATP [52,53,54,55,56], immunoblotting with anti-
phosphopeptide antibodies [57,58,59,60,61,62,63,64,65,66], studies with mutated IRS-1
[67,68,69] and HPLC online or offline interfaced with MALDI-TOF or ESI-TOF [70,71,72,73,74].
The large variation and poor reproducibility in the reported phosphorylation sites are
explained by: method sensitivities, enzymatic and chemical stabilities of the phosphorylated
sites and stimulus intensity /timing. Proposed mechanisms for impairment of the insulin
signaling system by phosphorylations of serine and threonine residues include: feedback
inhibition, cooperative interactions, uncoupling of the protein signaling network [75,76,77,78,
79] and ubiquitin-proteasome degradation [80,81,82,83,84,85,86]. It is fair to state that, to date,
burn-induced phosphorylations patterns of IRS-1 are poorly understood. However, since these
negative biological effects may provide some clues for exploring the mechanism of insulin
resistance [87,88,89], after burn injury [90,91], evaluation of this issue has become a major focus
of our laboratory.
Determination of the phosphorylation pattern of IRS-1 is essential for understanding the
metabolic basis for many disease processes [92]. However, neither the causative factors nor
the cellular mechanisms of the muscle wasting and insulin resistance associated with the
massive acute inflammation induced by burn injury have been elucidated. Recent publications
suggest that insulin resistance may be in part due to phosphorylation based negative-feedback
in two different pathways: 1) Phosphorylated Ser/Thr residues in the IRS-1 phosphorylated
tyrosine binding (PTB) domain may simply uncouple downstream processes from the insulin
receptor β - subunit, terminating downstream signal transduction without changing IRS-1
protein integrity. 2) Phosphorylated Ser/Thr sites may become proteolytic targets for CUL7 E3
ubiquitin ligase in a manner that depends on the mammalian target of rapamycin (mTOR) and
p70 S6 kinase activities. These Ser/Thr sites located in the proximal C-terminal region of IRS-1
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may provide multiple cleavage sites. Other studies have shown a role for SOCS-1 and SOCS-3
with the elongin BC ubiquitin ligase complex in IRS protein degradation.
There are 50 to 70 potential phosphorylation sites in IRS-1, and some of these sites up- and/or
down-regulate insulin signaling [93,94]. Sequencing of the human genome has allowed the
identification of more than 500 kinases and 60 phosphatases which may be involved in the
regulation of IRS-1 binding under physiological conditions [95]. To date, approximately 29
Ser/Thr phosphorylation sites in IRS1 have been reported from various in vivo and in vitro
experiments [96,97,98]. Unfortunately, no systematic IRS-1 phosphorylation data associated
with burn injury is currently available. Mapping of all the phosphorylation sites of IRS-1
remains a challenge issue. One of the major reasons for this is that intact IRS-1 is present at
very low concentrations (~ 51.9 ng/gram muscle tissues as described below); even in tissues in
which it is most abundant such as soleus muscle. However, it is possible to analyze these
phosphor-Ser/Thr residues in response to burn injury with tandem mass spectrometry.
Figure 1. Insulin resistance and muscle wasting: unsymmetrical two tales in murine burn model. Insulin resistance and
muscle wasting occurred at 10% and 70% likelihoods, respectively. IRS-1 integrity is reduced by 10% and thus is not a
major caustic factor in downstream signaling. However, impaired Akt1/PKBα activity by 70% due to enhanced S-nitro‐
sylation of Cys296 and reduction of phosphor-Thr308 and Ser473 has major impact on FOXO3 sub-cellular distribution and
activities. Muscle wasting is significant in burned vs sham treated animals after day 3 post-burn injuries, but insulin
resistance not significant under the same conditions.
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We hypothesis that burn-induced PTMs that alter insulin sensitivity and muscle wasting oc‐
cur not only at the IRS-1 level, but also at two critical downstream nodes: S-nitrosylated
Cys296 in the Akt1 kinase loop and acetylated Lys residues in FOXO3. Specifically, (1) the
docking platform integrity of IRS-1 may be partially disabled due to stress kinase mediated
Ser/Thrphosphorylations which become E3 ligase targets. In other words, the reduction in
glucose transport in skeletal muscle following burn injury may secondarily affect abundance
and/or phosphorylation of IRS-1. (2) S-nitrosylated Cys296 interacts with phosphor-Thr308 in
regulation of Akt1/PKBα kinase loop conformational changes which consequently inhibit
kinase activity. (3) In addition of FOXO3 phosphorylation and reversible acetylation play
major roles in transcriptional activities which trigger apoptosis and muscle wasting under
the conditions of impaired Akt1/PKBα and IGF1 signaling as in the above two hypothesis.
In contract to other biochemical approaches that are currently in use, all these PTM effects,
such as E3 ligases cleaved IRS-1 fragments as well as site specific PTMs, can only be unam‐
biguously analyzed with sensitive NanoLC-Q-TOF tandem mass spectrometry techniques.
However, a major limitation of this approach is the low abundance of the signaling proteins
for in vivo studies. Figure 1 illustrates the genesis of insulin resistance and muscle wasting at
several crucial nodes: insulin resistance has been observed at 10% likelihood, while muscle
wasting occurs at 70% likelihood in our murine models described below.
2. Materials
Methanol, acetonitrile (LC-MS Chromasolv, ACN), formic acid (FA), glacial acetic acid, LC-
MS grade water, dithiotheretol (DTT) and iodoacetic acid, iodoacetamide, [Glu1]-Fibrinopep‐
tide B, methyl methanethiolsulfonate (MMTS), S-nitrosoglutathione (GSNO), sodium L-
ascorbate, neocuproine, N,N-dimethylformamide (DMF), dithiothreitol (DTT), dimethyl
sulfoxide (DMSO), Trypsin digestion kits (#PP0100), Phenylmethanesulfonyl fluoride (PMSF,
cat# P-7626) and goat IgG were obtained from Sigma Chemical Co. (St. Louis, MO). SDS-PAGE
ready gels (7.5%, #161-1100), SDS-PAGE ready gels (12 % Tris-HCl, #161-1102),SDS-PAGE
ready gels (4-15% Tris-HCl, #161-1122), Laemmli sample buffer (#161-0737) and Coomassie
brilliant blue R250 (#161-0436) were obtained from BIO-RAD (Hercules, CA, USA). Streptavi‐
din agarose CL-4B was a product of Fluka (Cat#: 85881, Milwakee, WI). HPDP-Biotin (Cat#:
21341) and iodoacetyl-LC-Biotin (Cat#: 21333), immobilized monomeric avidin beads (Cat#:
20228), Iodoacetyl-LC-Biotin (Cat#: 21333) were purchased from Pierce (Rockford, IL).
Recombinant rat IRS-1 (#12-335, lot# 23015A purchased in 2005), assay buffer 5X (#20-145) and
Mg++/ATP 5X (#20-113), Anti-Akt1/PKBα monoclonal antibody (Cat# 05-798, Lot: 26860) and
inactive Akt1/PKBα (Cat#: 14-279) were obtained from Upstate Technology (Lake Placid, NY,
USA). Anti-ubiquitin (rabbit polyclonal, Ab19247) and anti-C-terminal IRS-1 (rabbit polyclo‐
nal, Ab653) antibodies were purchased from Abcam (Cambridge, MA, USA). Anti-N-terminal
IRS-1 (rabbit polyclonal, SC560) was obtained from Santa Cruz Biotechnology (Santa Cruz,
CA, USA). Protein G agarose (cat# 16-266) was obtained from Millipore (Billerica, MA, USA).
Cell lysis buffer (cat# 9803), anti-FOXO3 rabbit antibodies (Cat#2497) were purchased from
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Cell Signaling (Beverly, MA, USA). IRS-1 (total) ELISA kit (KHO0511), Akt pThr308 ElISA kit
(KHO0201) and pSer473 kit (KHO0111) were purchased from Invitrogen (Carlsbad, CA, USA).
TRI reagent solution (cat# AM9738) was a product of Applied Biosystem (Framingham, MA,
USA). 1-bromo-3-chloropropane (cat# BP 151) was purchased from Molecular Research
Center, Inc. (Cincinnati, OH, USA). Qproteome cell compartment kit (Cat#: 37502) was
obtained from Qiagen(Valencia, CA, USA).
The diet with depletion of L-Leu was obtained from Dyets, Inc., Bethlehem, Pennsylvania,
DYET #510133, meets 1995 NRC nutrient requirements. [isopropyl-2H7]-L-Leu was product of
Cambridge Isotope Lab (Andover, MA, USA).
Protein molecular weight markers (Cat#928-40000), secondary antibody (Cat# 926-3221, anti-
Rabbit IgG) were purchased from LI-COR Biosciences (Lincoln, NE, USA). All PCR primers
were obtained from the Massachusetts General Hospital primer bank.
3. Methods
3.1. Degradation of recombinant human IRS-1 stimulated with high insulin dose
Mammalian 293 cells were transfected with a recombinant IRS-1 FLAG tagged plasmid using
a liposome reagent and Opti-MEM medium to deliver the plasmid DNA into the cells.
Transfected cells were grown to confluence and placed in serum-free Dulbecco’s modified
Eagle’s medium. The cells were then treated with insulin (1 μM) for 10 min. The medium was
aspirated, and the cells were lysed in Reporter lysis buffer with phosphatase cocktail inhibitors
containing 50 nM Potassium Bisperoxo(bipyridine)oxovanadate and 5 nMCalyculin A
(Discodermia calyx) at 4oC. Fragments of Flag-IRS-1 C-terminal were immunoprecipitated
with mAb to the first C-terminal 14 amino acid residues of IRS-1. The reaction mixtures were
gently stirring in PBS (200 ml) at 4oC for 1 hr and excess mAb was removed with PBS (1 ml x
3). Flag-IRS-1 was released and cysteine residues were alkylated with Laemmli sample buffer
(with 3% 2-mercaptoethanol, 100 mM DTT, 50 ml) for 5 min at 95oC and then 1 hr at room
temperature under stirring. The reaction mixtures were separated by SDS-PAGE (7.5% Tris-
HCl); IRS-1 bands stained with Coomassie brilliant blue R-250 were excised. In-gel trypsin
digestion was performed (0.4 μg trypsin in 70 ml reaction buffer, 37oC, and overnight).
3.2. Mouse burn model
The protocol for the studies was approved by the Massachusetts General Hospital and Shriners
Hospital for Children Animal Care Committees. Our animal care facility is accredited by the
Association for Assessment and Accreditation of Laboratory Animal Care. Male CD-1 mice
(Charles River Breeding Laboratories, Wilmington, MA, USA) weighing about 22-25 g were
used. Sixteen animals were used for full thickness third degree burn injury produced under
anesthesia (ketamine xylazine). After clipping of back hair, animals were placed in a template
designed to expose 25% of their dorsum, and immersed into a water bath at 90?C for 9 second.
After burn, the animals were immediately resuscitated with saline (2ml / mouse) by intraper‐
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itoneal injection. Buprenorphin (0.1 mg/kg, I.P.) was administered every 6-12 hours after
injury. The sham group (n=5, matched for weight) was treated in the same manner as the burn
group (n=14) with the exception that they were exposed to warm water (~36oC). The mice were
sacrificed by cervical dislocation and skeletal and liver were dissected and quickly placed in
liquid nitrogen. All biological studies were performed with skeletal muscle excised from the
animals at day 7 after burn injury or sham treatment.
3.3. Skeletal muscle preparation
Due to sequence analysis using NanoLC-Q-TOF tandem mass spectrometry for very low
abundant IRS-1 in muscle, total whole body skeletal muscle (~2.5-3.0 g/animal) was evaluated;
fast and slow twitch muscles could not be studied independently. The muscle groups studied
included: trapezius, gluteus superficialis, rectus femorus, latissimusdorsi, shoulder deltoid,
serratus anterior, vastusmedialis, semitendinosus, biceps femoris, adductor longus, gracilis,
triceptsbrachi, soleus and rectus abdominus. The muscle was harvested by careful dissection
which excluded skin, bone and other non muscular tissues. Immediately after dissection, tissue
samples were immersed in liquid nitrogen. Frozen tissue samples were cut into pieces smaller
than ~50 mg, and homogenized by 5 strokes over 30 seconds (full speed, model CTH-115, Cole
Parmer). For tandem mass spectrometry, muscle tissue samples were processed in freshly
prepared Cell Signaling lysate buffer (5 ml per gram tissue) containing fresh PMSF (1mM) on
ice. Homogenates were sonicated briefly in ice cold water, and centrifuged at 14,000 g for 10
minutes at 4oC. Supernatants were collected and stored at -80oC for further studies.
3.4. IRS-1 in-gel digestion
skeletal muscle were processed in freshly prepared Cell Signaling lysate buffer (5 ml per 1
gram tissues) containing fresh PMSF (1 mM) on ice. The homogenates were sonicated briefly
in ice-cold water, and centrifuged at 14,000 g for 10 minutes. The supernatants were collected
and mixed with protein G agarose beads (100 ml, 50% slurry) for 2 hours to remove IgG and
non-specific proteins. The protein G beads were removed by centrifugation at 14,000 g for 30
seconds. Anti-C-terminal IRS-1 antibody (Ab653, 2 ml) was added to the supernatants to
immunoprecipite IRS-1 (overnight at 4oC). The immune complexes were recovered by adding
protein G agarose slurry (50%, 100 ml) with rotating for two hours at room temperature. The
recovered beads (~ 50 ml) were washed (six times) with PBS (1 ml) and treated with Laemmli
sample buffer (2X, 50 ml) containing 2-mercaptoethanol (3%, v/v, 100 mM DTT) at 95oC for 5
min. SDS-PAGE separation and in-gel trypsin digestion were described as above.
3.5. Skeletal muscle IRS-1 ELISA
Mouse skeletal muscle tissue (20 mg) was homogenized with a TissueRuptor using a Qpro‐
teome cell compartment kit according to the manufacture’s protocol. IRS-1 C-terminal
fragments in cytosolic, membrane, nuclear and cytoskeletal fractions were measured using
IRS-1 (total) ELISA kit. Homogenate aliquots (100 μl) from muscle tissue harvested from 16
burned and 8 sham treated muscle tissues were diluted with Standard Diluent Buffer (400 μl)
provided from the ELISA kits. IRS-1 standard calibration curves were prepared according to
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the manufacturer’s protocol. Diluted tissue lysates (100 μl) were pipetted into the 96-well
plates. The ELISA plates were gently shaken to capture IRS-1 at 4oC overnight. Rabbit anti-
ubiquitin antibody, rabbit anti-N-terminal IRS-1 antibody and rabbit anti-C-terminal IRS-1
antibody were diluted by 500 fold using horseradish peroxidase (HR) diluents at room
temperature. After six washings (0.4 ml Wash Buffer, gentle shaking for 30 seconds) at room
temperature, rabbit anti-IRS-1 antibody provided with the IRS-1 ELISA kit together with the
three detection antibodies (100 μl) were pipetted into each well. Detection was performed by
gentle shaking with the detection antibodies at room temperature for 1 hour. After removal of
excess detection antibodies, anti-rabbit IgG-HRP antibody was added and analyzed according
to the manufacturer’s directions.
3.6. RT-PCR analysis of degradation pathways
To understand the roles of FOXO3 in skeletal muscle wasting as well as to evaluate FOXO3
degradation, we need to first distinguish FOXO3 and 14-3-3γ mediated proteasomal proteol‐
ysis (MuRF1, MAFbx/atrogin1) and lysosomal autophagy (Bnip3, Atg4a, Atg12, Gabarapl1)
degradation pathways at the mRNA level. These studies will be performed in both thermally
injured (n=16) and sham treated animals (n=6). Skeletal muscle excised from the animals on
day 3,7 and 14 after burn injury or sham treatment is frozen, tissue samples (~50 mg) are cut
into small pieces in RNase-free tubes, and homogenized with 5 strokes (5 seconds each) of an
Omni TH-tissue homogenizer in sterilized Eppendorf tubes (2 ml) containing TRI reagent
solution. RNA extraction is performed according to the TRI standard protocol. With this
procedure the average 260nm/280nm ratio is ~ 1.95, and the RNA yield is ~1.2 μg/mg skeletal
muscle. The quality of the isolated RNA is assessed with agarose gel electrophoresis. Samples
are analyzed in triplicate using the comparative threshold cycle SYBR green method. Expres‐
sion levels of target genes are corrected by normalization to the expression level of GAPDH,
and relative expression levels are calculated: ΔCt=Ct(target gene)- Ct(GAPDH),
ΔΔCt=ΔCt(burn) - ΔCt(sham), targeted gene normalized to the endogenous reference is given
by: 2-ΔΔCt. The primers that will be used for RT-PCR are tabulated below (F= forward, R=re‐
verse):
FOXO3 F: CCTACTTCAAGGATAAGGGCGAC, R: GCCTTCATTCTGAACGCGCATG
14-3-3γ F: GGACTATTACCGTTACCTGGCAG, R: CTGCATGTGCTCCTTGCTGATC
MuRF1 F: TACCAAGCCTGTGGTCATCCTG, R: TCTTTTGGGCGATGCCACTCAG
Bnip3 F: GCTCCAAGAGTTCTCACTGTGAC, R: GTTTTTCTCGCCAAAGCTGTGGC
Atg4a F: CAGTCTCCACAGCGGATGAGTA, R: GTGTGATGGGTGCTTCTGAACC
Atg12 F: GAAGGCTGTAGGAGACACTCCT, R: GGAAGGGGCAAAGGACTGATTC
Gabarapl1 F: GTGGAGAAGGCTCCTAAAGCCA, R: AGGTCTCAGGTGGATCCTCTTC
GAPDH F: GTCTCCTCTGACTTCAACAGCG, R: ACCACCCTGTTGCTGTAGCCAA
Table 1. PCR primers for proteasomal proteolysis and lysosomal autophagy analysis
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Using these primers, GAPDH mRNA levels were not significantly different between burned
and sham treated mice 16.12 ±0.93 vs 15.62±2.98 (p=0.162, unpaired t-test).
3.7. Mapping of Akt1/PKBα cysteine residues
Inactive Akt1/PKBα (10 μg, 0.18 nmol, in 10 μl stock solution) was transferred into a siliconi‐
zedEppendorf tube (0.6 ml) containing Laemmli sample buffer (2X,10 μl, pH adjusted to 8.0)
and DDT (2 μl, 20 nmol, PBS, pH = 8.0) and the solution was kept at 95oC for 5 min. Freshly
prepared iodoacetyl-LC-Biotin (15 μl, 55 nmol, in DMF) was added to the denatured protein
solution followed by stirring for additional 15 min at room temperature. The resulting
biotinylated Akt1/PKBαwas purified by SDS-PAGE (4-15% Tris-HCl) and stained with
Coomassie brilliant blue R-250. The protein bands were excised (~ 1 mm size) and digested
(Akt1/PKBα: trypsin = 25, over night at 37oC) with a trypsin profile IGD kit. The biotinylated
peptide mixture was captured by gentle stirring with streptavidin agarose CL-4B (30 μl
packed) at room temperature for 1 hr (final vol. 100 μl). The streptavidin beads were washed
with PBS (0.5 ml x 3), followed by water/acetonitrile (ACN 10%, 0.5 ml x 3). Biotinylated
peptides were released from the streptavidin beads with formic acid (FA, 70%, 100 μl) at room
temperature for 15 min with brief vortexing. The supernatant containing biotinylated peptides
was transferred into a new vial and the formic acid was evaporated with a SpeedVac. The
biotinylated peptide mixture was resuspended in water/acetonitrile (ACN, 2%, with 0.1% FA,
70 μl) and aliquots (10 μl) were analyzed.
3.8. Identification of disulfide bonds in inactive Akt1/PKBα
Inactive Akt1/PKBα (10 μg, 0.18 nmol, in 10 μl stock solution) was transferred into a siliconi‐
zedEppendorf tube (0.6 ml) containing Laemmli sample buffer (2X, 10 μl, pH = 8.0) and
iodoacetamide (2 μl, 20 nmol, PBS, pH = 8.0). The mixture solution was kept at 950C for 5 min
and stirred at room temperature for additional15 minutes. The Akt1/PKBαderivative was
purified by SDS-PAGE (4-15% Tris-HCl) and stained with Coomassie brilliant blue R-250. The
protein bands were excised (~ 1 mm size) and digested (Akt1/PKBα: trypsin = 25, overnight)
with a trypsin profile IGD kit. Supernatant (~ 70 μl) was neutralized with formic acid (5 μl)
and aliquots of the final solution (10 μl) were analyzed.
3.9. Analysis of NO acceptor sites in inactive Akt1/PKBα
Three samples of inactive Akt1/PKBα (10 μg, 0.18 nmol, in 10 μl stock solution) were treated
with GSNO (250 nmol, 50 μl PBS, pH = 8.0) for 5 min at room temperature in the dark in
siliconizedEppendorf tubes (0.6 ml). Separation of Akt1/PKBα and GSNO was achieved by
two successive acetone/water precipitations (0.3 ml, 70% ACN) at – 40oC for 10 min. The
supernatants (containing GSNO) were removed by centrifugation at 14,000 X g for 2 minutes.
The kinase pellets were resuspended in blocking buffer (100 μl, 20 mMTris-HCl, pH 7.7, 2.5%
SDS, 20 mM MMTS, 1 mM EDTA, 0.1 mMneocuproine) at room temperature for 1 hr with
gently stirring (I mm ID X 5 mm bar). Excess MMTS was removed by acetone (100%, 0.3 ml)
precipitation (as above) and the protein pellets were resuspended in PBS (50 μl, pH = 8.0).
Freshly prepared iodoacetic acid (5 μl, 2 mM in PBS, pH = 8.0), Biotin-HPDH (5 μl, 2 mM in
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DMSO), iodoacetyl-LC-Biotin (5 μl, 2 mM in DMF) and sodium ascorbate (20 μl, 5 mM, PBS)
were added to the three vials containing nitrosylated Akt1/PKBα. The reaction mixtures were
stirred at room temperature for 5 min (iodoacetic acid and iodoacetyl-LC-Biotin) or 1 hr for
the thiol-disulfide exchange reaction. Aliquots of SDS sample buffer (2x, with 3% 2-mercap‐
toethanol, 100 mM DTT, 50 μl) were added to the protein solutions and the mixtures were
incubated at 95oC for 5 min. The derivatized proteins were separated with SDS-PAGE Ready
gels. The gels were stained with Coomassie brilliant blue R-250 and the Akt1/PKBα bands were
excised as 1 X 1 mm pierces. The proteins were digested with the trypsin profile IGD kit.
Carboxylmethylcysteine (CMC) containing peptides were neutralized with FA (5 μl) and
sequenced via parent ion discovery trigged by the CMC immonium ion (134.02 ± 0.05 mDa).
Biotinylated peptides were sequenced with data dependent acquisition after capture with
streptavidin agarose beads. Ten μl aliquots of each final solution were analyzed.
3.10. Analysis of the Cys296-Cys310 disulfide bond formation in Akt1/PKBα after treatment
with S-nitrosoglutathione
Inactive Akt1/PKBα (10 μg, 10 μl, 0.18 nmol) and freshly prepared GSNO (5 μl, 250 nmol, PBS,
pH = 8.0) were stirred in an Eppendorf tube (0.6 ml) in the dark at room temperature for 1 hr.
Separation of Akt1/PKBα and GSNO was performed with acetone/water (70%) as above. The
kinase pellet was resuspended in PBS (10 μl) and SDS sample buffer (with 100 mM of iodoa‐
cetamide, 10 μl, 1 mmol) was added. The cysteine alkylation was performed at room temper‐
ature for 15 min. The protein samples were separated with SDS-PAGE Ready gels and digested
as above. Aliquots of the final solution (10 μl) were analyzed.
3.11. Measurement of the free and disulfide bonded Cys296 in Akt1/PKBα from soleus muscle
of burned rats
The lysates (~10 mg/ml total soleus proteins) were diluted to about 3-5 mg protein / ml protein
with PBS, and filtered through 0.22 μm membranes. Immunoprecipitation was performed as
following: anti-Akt1/PKBαmAb (Upstate, clone AW24, 5 μg) and prewashed protein G agarose
beads (50 μl, packed) were kept at 4oC for 1 hrs under gently stirring, without washing the
beads, the soleus lysates (5 ml) were added and maintained under stirring for another 90
minutes. The non-specific proteins were washed with PBS three times, then treated with
Laemmli sample buffer (pH adjusted to 8) containing acetyl-LC-Biotin (400 μM) at 95oC for 5
min. The procedures for SDS-PAGE separation and in-gel trypsin digestion were the same as
described above.
3.12. Metabolic labeling with [isopropyl-2H7]-L-Leu and natural L-Leu Diets
The diet with depletion of L-Leu was obtained as L-amino acids defined diet for rats and mice.
For producing the light diet, natural L-Leu was added to the diet powder (1% by weight) and
producing the heavy diet, the same amount of [isopropyl-2H7]-L-Leu was added to the diet
powder. For both diets, a minimal amount of water was added to make biscuits of adequate
size. The biscuits were dried at room temperature for 1 week as suggested by Dyets in order
to maintain the original nutrients. Burned and sham treated mice were caged separately and
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maintained in a temperature controlled facility with a 12-h light/dark cycle. Burned mice were
fed with the diet containing [isopropyl-2H7]-L-Leu and sham treated mice fed with the diet
containing natural L-Leu. Five grams of light and heavy diets were provided daily to each
mouse for 7 days. The animals had ad libitum access to water.
3.13. Biotinylation of Cys296 in Akt1/PKBα kinase loop
Following immunoprecipitation of metabolically labeled Akt1/PKBα, Laemmil sample buffer
(50 μl, X2) was added to the washed immunocomplex beads (packed 50 μl, washed with PBS,
1 ml X three 5 min cycles). This was followed by addition of freshly prepared Iodoacetyl-LC-
Biotin solution (10 μl, stock solution: 2 mg in 1ml of DMF). Cysteine acylation was performed
at room temperature for 15 min with stirring. The reaction was quenched by addition of 2-
mercaptoethanol (5 μl). The beads were then heated at 95oC for 5 min and kept at room
temperature for 30 min prior to loading on SDS-PAGE gels.
3.14. Avidin purification
Immobilized monomeric avidin beads (30 μl, 50 % aqueous slurry) were placed in siliconized
polypropylene Eppendorf tubes (0.6 ml), and washed with PBS. The digested peptides (70 μl)
were added to the packed avidin beads (15 μl) and the mixture was placed on a rocking
platform for 30 min to capture the biotinylated peptides. Supernatant was collected, dried via
Speed-Vac, and resuspended in mobile phase A (as described below, 15 μl) for control peptide
252FYGAEIVSALDYLHSEK268 analysis. The beads were then washed with PBS (200 μl X 3),
followed by ACN/water (10/90 = v/v, 200 μl X 3). The biotinylated peptides were recovered by
addition of formic acid (30 μl, 70%) and gently rocking for 5 min at room temperature. This
recovery step was repeated three time and the supernatants were combined, dried via Speed-
Vac, and resuspended in mobile phase A (15 μl) for biotinylated loop peptide 290ITDFGLCK297
analysis.
3.15. Measurements of skeletal muscle Akt1 pThr308 and pSer473
According to the manufacture’s protocols of the pThr308 and pSer473 ELISA kits, one unit of
phosphorylation standard is defined as the amount of Akt pThr308 or pSer473 derived from 500
pg or 100 pg of Akt protein, which is phosphorylated by MAPKAP 2 and PDK 1. Muscle tissues
lysates obtained with the Cell Signaling buffer described as above were used for measurement
of Akt pThr308 and pSer473. The phosphorylation levels were normalized to tissue weight.
3.16. Western blot and acetylation characterization of muscle FOXO3 post burn injury
Immunoprecipitations of muscle lysates from burned and sham treated mice were performed
using anti-C-terminal antibody (sc-34895, 2 μg). SDS-PAGE was performed with 12% Ready
Gels and protein molecular weight markers. Western blot analysis was performed with
primary rabbit antibodies (Cell Signaling, Cat#2497, 20 μl + Tween-20, 20 μl + Odyssey blocking
buffer, 20 ml) at 4oC overnight, and secondary antibody (Odyssey, Cat# 926-3221, anti-Rabbit
IgG 2 μl + Tween-20 20 μl + Odyssey blocking buffer, 20 ml) at room temperature for 1 hour.
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The membrane was scanned over near-infrared range. Recombinant human FOXO3 was
loaded onto the 12% Ready Gels with intact and reduced goat IgG. Two FOXO3 bands were
also found with molecular weights of above 87 and 80 kDa as compared with intact IgG (150
kDa) and reduced IgG heavy chains (50 kDa). The FOXO3 bands were digested and analyzed
for acetylation using DDA approach.
3.17. NanoLC-Q-TOFmicro
All experiments were performed using a Waters CapLC-Q-TOFmicro system (Waters Corpora‐
tion, Milford, MA, USA). An analytical column (75 μm I.D. X 150 mm, Vydac C18, 5 μm, 300
A, LC Packings, Dionex Company, San Francisco, CA) was used to connect the stream select
module of the CapLC and the voltage supply adapter for ESI. After washing with mobile phase
C (auxiliary pump, 0.1% formic acid in water/acetonitrile, 2% acetonitrile) for 2 minutes, the
trapped peptides were back washed from the precolumn onto the analytical column using the
10-position stream switching valve. A linear gradient was used to elute the peptide mixture
from mobile phase A (0.1% FA in water/ACN, 2% ACN) to mobile phase B (0.1% FA in ACN).
The gradient was segmented as follow: isocratic elution with 2% solvent B for 3 min, 2-80 %
solvent B from 3 to 45 min and 80 to 2% B from 45-50 min. The gradient flow rate was adjusted
to ~70 nl/min. The electrospray voltage was set to ~ 3000 V to obtain an even ESI plume. Sample
cone and extraction cone voltages were set at 45 and 3 V, respectively. The instrument was
operated in positive ion mode with the electrospray source maintained at 90oC. The instrument
was calibrated with synthetic human [Glu1]-Fibrinopeptide B (100 fmol/μl in acetonitrile/water
= 10:90, 0.1% formic acid, v/v) at an infusion rate of 1 μl/min in TOF MS/MS mode. The collision
energy was set at 35 V. Instrument resolution for the [Glu1]-Fibrinopeptide B parent ion, m/z
= 785.84, was found to be ~5000 FWHM. Neutral loss for p-Ser and p-Thr parent ion discovery
was set at 97.977 ± 0.03 Da with CE 35 and 5 V, respectively. All data were acquired and
processed using MassLynx 4.1 software.
4. Results and discussion
4.1. Phosphorylated Ser/Thr triggers skeletal muscle IRS-1 C-terminal degradation
A total of 260 tryptic IRS-1 peptides, both doubly and triply charged under ESI, were located
within the Q-TOF mass survey window setting (from m/z 400 to 1200). The chromatographic
elution time window was ~30 min under our NanoLC gradient conditions and it was impos‐
sible to chromatographically separate the digested IRS-1 peptide mixture at the single peptide
level; since many of the tryptic peptides overlapped. To overcome this problem, up to eight
precursor ions were set for MS survey which provided secondary mass resolution in addition
to the chromatographic separation. False positive precursor ions attributable to contamina‐
tions were eliminated by IRS-1 MS/MS sequence analysis. The NanoLC interfaced with Q-TOF
settings that we used also had some false negative discoveries. These missed precursor ions
may be due to their week hydrophobic properties (escaping from the trapping C18 column for
desalting), week ionization, miss-digestion of large peptides and chemical alternations in
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predictable peptide structures. However, the confidently identified precursor ions represent
desirable candidate peptides for in vivo phosphorylation studies. Thus, unambiguously
discovered peptides were selected as relative MS fingerprints for IRS-1 protein expression as
well as PTM analysis in insulin treatment studies. Confirmation of the phosphorylation of Ser/
Thr sites was performed by the following three step procedure: (1) Phosphorylated parent ion
discoveries by MS survey via neutral loss (H3PO4) or phosphor-Tyr immonium ion approaches;
the peptide mass tolerance was set at 0.2 Da; (2) Analysis of candidate parent ions with PepSeq
of MassLynx V4.1 software to verify IRS-1 tryptic peptide sequences. Mercaptocysteine was
searched as a fixed modification, whereas oxidation of methionine and phosphorylations were
searched as variable modifications. (3) Confirmations of phosphorylated Ser/Thr sites with the
diagnostic mass difference of 80.00 ± 0.15 Da (HPO3 moiety) between phosphorylated and non-
phosphorylated y or b ions, as well as phosphor-Tyr containing ions with S/N > 2. Figure 2, 3,
4 demonstrate the neutral approach to identify phosphor-Ser/Thr sites, while tryptic peptides
containing phosphor-Tyr sites are as shown in Figure 5, 6, 7.
Figure 2. NanoLC base peak ion chromatogram of tryptic IRS-1 parent ion discovery with the neutral loss approach.
Top panel: TOF MS/MS BPI chromatogram of IRS-1 doubly charged tryptic peptide 298SRTESITATSPASMVGGKPGSFR320
(m/z 776.43), eluted at retention time 19.97 min, discovered with neutral loss of H3PO4. Bottom panel: TOF MS BPI
neutral loss survey chromatogram obtained with collision energy 5 V.
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Figure 4. The zoom spectrum of Figure 3 shows diagnostic phosphor-Ser318 in the 298SRTESITATSPASMVGGKPGpSFR320
peptide. Non-phospho-y8 ion (GGKPGSFR, m/z 805.56) and phosho-y8 ion (GGKPGpSFR, m/z = 885.43) indicates
Δmass shift of 79.87 Da for HPO3 modification.
Figure 3. Sequence profile of IRS-1 phospho-Ser/Thr peptide acquisition triggered with the neutral loss approach.
Doubly charged tryptic298SRTESITATSPASMVGGKPGSFR320 (m/z 776.43) parent ion eluted at 19.97 min as shown in the
top panel Figure 2. The y ion series ranging from y5 to y13 confirm the correct sequence.
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Figure 5. NanoLC base peak ion chromatogram of tryptic IRS-1 parent ion discovery with phospho-Tyr immonium ion
approach. Top panel: phospho-Tyr parent ion eluted at retention time 21.31 min with triply charged m/z 879.28. Sin‐
gly charged contaminant eluted at retention time 18.22 min with m/z 308.27. Immonium ion survey collision energy
was kept between 5 and 100 V. Bottom panel: TOF MS BPI p-Tyr immonium ion survey chromatogram obtained with
collision energy 5 V.
Having validated the site specific phosphorylation methods as described above, an invitro
transfected IRS-1 model system was developed in order to analyze those stress induced
phosphorylation sites and its degradation Typical MS/MS sequence data of insulin dependent
phosphorylation sites pSer641 are shown in Figure 8.
The striking insulin dependent phosphorylation pattern indicates that pThr475, pThr477 and
pSer641 were induced by high dose insulin stress. These phosphorylated sites at high dose
insulin stimulation provided the first clue for understanding possible mechanism(s) for insulin
resistance up stream of the insulin/IRS-PI3K-Akt-FOXO and growth factors-PI3K-Akt-FOXO
pathways. In order to evaluate IRS-1 degradation at these phosphorylation sites, SILAC was
used for relative quantification of IRS-1 at the insulin dosage. Tryptic peptide T23 (162EVWQ‐
VILKPK171) labeled with heavy isotope (under insulin stress) and light isotopes (without
insulin) was used as a mass marker to evaluate IRS-1 protein level. Relative peak areas of
precursor peptides indicated that at least 50% of IRS-1 was degraded rapidly. The critical
question is whether IRS-1 degradation is trigged at the three phosphorylated sites? The
predicated C-terminal fragment cleaved at sites pThr475 /pThr477 is expected at 80,673 Da and
the second fragment cleaved at site pSer641 expected at 64,441 Da. When C-terminal specific
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mAb was used to repeat the insulin stimulation studies, SDS-PAGE showed that the IRS-1
band was reduced by ~50% with insulin stress as compared with the control; which is in
agreement with the SILAC result. The multiple bands located between 50 kDa (IgG heavy
chain) and 100 kDa (dimmer of heavy chain, 2-mercaptoethanol and DTT are not sufficient to
achieve complete reduction of all disulfide bonds) were excised, digested and subjected to
NanoLC-Q-TOF sequence analysis. The 65% sequence coverage confirmed that the FLAG
tagged human IRS-1 bands were slightly lower in MW than the standard rat IRS-1 band. One
fragment band (~ 80 kDa estimated from SDS-PAGE) was confirmed with two human IRS-1
sequences: 639SVSAPQQIINPIR651 and 1017TGIAAEEVSLPR1028. At the same time the cleavage
site precursor ion (472GPSPTLPTAPNGHYILSR487) was no longer detected. Another fragment
band (~ 65 kDa from SDS-PAGE) was confirmed with 1017TGIAAEEVSLPR1028 only. For the
same reason, the precursor ion (639SVpSAPQQIINPIR651) corresponding to this cleavage was
missed from our MS survey list. These three facts confirm a negative regulated mechanism:
stressed cells at the high insulin dose activate unknown kinases to phosphorylate threonine
and serine residues located in the middle of the C-terminus of IRS-1 (for human IRS-1, C-
terminus refers from the PTB domain residue aspartic acid 262 to the last glutamine 1242) and
the multiple phosphorylated sites may trigger the ubiquitin-proteosome pathway to yield
these major fragments. The C-terminus of IRS-1 cleaved around pThr475 /pThr477 afforded the
fragment with MW ~ 80 kDa, while the fragment with MW ~65 kDa was related to pSer641. The
Figure 6. Sequence profile of phopspho-Tyr489 peptide acquisition triggered with the immonium ion approach. Triply
charged Parent ion 489YIPGATMGTSPALTGDEAAGAADLDNR515 (m/z 879.28)elutedat 23.31 min as shown in the top
panel of Figure 5, MS/MS acquisition was obtained with collision energy of 35 V. The y ion series ranging from y5 to
y13 confirmed the correct sequence.
Tandem Mass Spectrometry - Molecular Characterization152
observation that serine phosphorylation decreases insulin-stimulated tyrosine phosphoryla‐
tion of IRS-1 and the observation of proteolytic turnover of the protein suggest the IRS-1
functions in both positive (N-terminal) and negative (C-terminal) feedback loops, The negative
feedback is related to serine phosphorylation at the N-terminal half of the protein, with the C-
terminal boundary at approximately amino acid residue 574 [99]. Positive signaling effects at
low insulin dosages were associated with pSer308, pThr305 and pTyr1012. Phosphorylated
Tyr1012 may be the one of the downstream SH2 domain binding sites since it possesses the
characteristic sequence YADM. Thus the sequence specific Ser/Thr kinase list might present
pharmaceutical targets for modulating insulin resistance.
In vitro phosphorylation sites of rat IRS-1 C-terminal region provided “similarity” degradation
references for further in vivo studies. The IRS-1 fragment sizes estimated from SDS-PAGE and
their sequences are listed in Table 2.
For quantitative measurement of IRS-1 degradation in muscle of burned mice, additional
studies were performed to explore sub-cellular distributions, C-terminal fragments and
ubiquitinated IRS-1. An antibody specific to the 14 C-terminal amino acid residues of IRS-1
was used to capture IRS-1 irrespective of its post-translational modifications and integrity.
Subsequently anti-ubiquitin, anti-C-terminal and anti-N-terminal polyclonal antibodies were
used as the primary antibodies for ELISA analysis. The sub-cellular distribution of skeletal
Figure 7. The zoom spectrum of Figure 6 shows Diagnostic phospho-Tyr489 in the IRS1 triply charged parent ion
489YIPGATMGTSPALTGDEAAGAADLDNR515. Non-phospho-b1 ion (Tyr, m/z 164.07) and phosho-b1 ion (pTyr, m/z =
244.11) indicates Δmass shift 80.04 for the HPO3 modification.
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muscle IRS-1 post-burn injury is illustrated in Figure 9. The physiological distribution pattern
in sham treated mice demonstrates nearly equal amounts of membrane bound IRS-1 (102.7 ng/
g) and the IRS-1 in the cytosolic and nuclear compartments (49.1 and 44.9 ng/g). No detectable
IRS-1 was observed in the cytoskeletal compartment.
The total cellular IRS-1 from the three compartments was found to be 196.7 ng/g. Results with
the anti-N-terminal antibody data indicated that about 26.3% of the IRS-1 pool remained as
intact protein. Thus, the majority of IRS-1 was present as C-terminal fragments. Ubiquitinated
Figure 8. Analysis of pSer641 peptide of recombinant human IRS-1 stimulated with high insulin dose. Doubly charged
parent ion was discovered with the neutral loss approach: [M+2H]2+ = 711.91, 639SVpSAPQQIINPIR651. 639Ser-Val, b2 ion
= 187.12. No corresponding phosphorylated 639Ser b2 ion was observed, however, 639Ser-Val-Ser641, b3 ion at m/z =
274.14 and phosphorylated b3 ion at m/z = 354.17 (Δmass = 80.03 Da), indicated phosphorylation of Ser641 rather
than Ser639.
position M+H+ Sequence Sequenced in SDS-PAGE bands(kDa)
1170-1180 1263.67 SLNYIDLDLAK 95, 44, 42
1156-1169 1363.61 ESAPVCGAAGGLEK 95, 44, 42
993-1010 1984.92 QSYVDTSPVAPVSYADMR 44
1135-1155 2242.11 HSSASFNVWLRPGDLGGVSK 95
Table 2. Tandem mass spectrometry (MS/MS) characterization of mouse skeletal muscle IRS-1 C-terminal fragments
after burn injury
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IRS-1 was found to represent 12.4% of total IRS-1. Burn-induced changes in the sub-cellular
distribution of IRS-1 were clearly driven by the 15.9 % increase in ubiquitination. Consequent‐
ly, total IRS-1 in the three sub-cellular compartments was reduced by 55.8%, while intact
cellular IRS-1 was decreased by 7.7%. A striking feature revealed from the sub-cellular
distribution pattern of IRS-1 is that equilibrium between the cytosolic and nuclear compart‐
ments occurs by day 7 after burn injury.
The level of intact IRS-1 protein was found to be only ~51.9 ng/g in the skeletal muscle, which
is too low to map phosphorylation sites with tandem mass spectrometry. However, those burn-
induced phosphor-Ser/Thr sites provide one to get into the insight of the mechanism of insulin
resistance and muscle wasting at the initial Ins/Ir/IRS-1 signaling transduction level. On the
other hand, with the mixed-muscle preparations that were evaluated, it was not possible to
determine the percentage of slow and fast twitch fibers. These issues in conjunction with the
small amount of skeletal muscle harvestable from mice, the low level of IRS-1 in muscle and
the low sensitivity of the site specific MS/MS sequencing for low abundant phosphorylated
residues are an unavoidable limitation of current studies. The in vitro and in vivo IRS-1 data
suggest that in 8-10 week old mice with burn injury insulin resistance occurs in only ~10% of
the animals. The observations that significant muscle wasting occurs both clinically and in
animal models (~70% of animals) suggest a pivotal role for downstreamAkt1/PKBα.
Figure 9. Quantitative measurement of IRS-1 integrity and sub-cellular distribution. IRS-1 was captured with anti-C-
terminal mAb, and detected with anti-ubiquitin, anti-N-terminal, and anti-C-terminal rabbit polyclonal antibodies. For
total intact and ubiquitinated IRS-1, sub-cellular components were isolated using a Qproteome cell compartment kit
according to the Qiagen protocol. Values represent mean ± sem for 14 burned and 5 sham treated mice. *: p<0.05, **:
p<0.005.
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4.2. S-nitrosylated Cys296 catalyzes disulfide bond formation with Cys310 in Akt1/PKBα||
active loop
Akt1/PKBα is a central mediator of the IR/IRS/ PI3K/FOXO pathway. In addition, to the role
of reversible phosphorylation/ dephosphorylation at Thr473 and Ser308 in its regulation,
reversible inactivation can also be mediated by S-nitrosylation at cysteine residues. We
performed in vitro and in vivo studies to verify this hypothesis. Here, for the first time, tandem
mass spectrometry data revealed that S-nitrosylated Cys296 mediates kinase loop conforma‐
tional changes mediated via S-nitrosylation and phosphorylation.
For the in vitro studies, Akt1/PKBα was S-nitrosylated with the NO donor S-nitrosoglutathione
(GSNO) and derivatized by 3 methods. The derivatives were isolated by SDS-PAGE, trypsi‐
nized and analyzed by tandem MS. For the in vivo studies, Akt1/PKBα in muscle lysates from
burned rats was immunoprecipitated, derivatized with HPDP-Biotin and analyzed. The in
vitro studies provided unambiguous MS fingerprints for the in vivo studies. The invivo studies
demonstrated that NO free radical reacts with the free thiol of Cys296 to produce a Cys296-SNO
intermediate which accelerates interaction with vicinal Cys310 to form a Cys296-Cys310 disulfide
linkage, at the same time, dephosphorylation at Thr308 was observed. The disulfide bond
between Cys296 and Cys310 was not detected in lysates from sham animals. As a result of this
dual effect produced by burn injury, the loose conformation that is slightly stabilized by the
kinase loop Lys297-Thr308 salt-bridge may be replaced by a more rigid structure which may
block substrate access and down-regulate activity. S-nitrosylated C296, located inside the Akt1
activity loop, was observed in tryptic peptide ITDFGLCK. Also, significant reductions in
phosphorylation of Ser473 and Thr308 of Akt1 were measured as 26.2% (p<0.05) and 49.8%
(p<0.005), respectively.
Akt1/PKBα consists of three structural features: the N-terminal pleckstrin homology (PH)
domain, a large central kinase domain and a short C-terminal hydrophobic motif. High specific
binding of the PH domain with membrane lipid products of PI3-kinase recruits Akt1/PKBα to
the plasma membrane where phosphorylations of Thr308 in the kinase domain and Ser473 located
in the C-terminal hydrophobic motif occur. Phosphorylation of Thr308 partially stimulates
kinase activity; however, additional phosphorylation of Ser473 is required for full activity.
Activation is associated with a disordered to ordered transition of a specific αC helix of Akt1/
PKBα via an allosteric mechanism. A salt bridge between the side-chain of Lys297 and the
phosphate group of pThr308 in this αC helix contributes to an ordered activation segment from
292DFG to APE319 [99,100,101,102]. Reversible dephosphorylations of Thr308 and Ser473 by protein
phosphatase 2A (PP2A) and PH domain leucine-rich repeat protein phosphatase (PHLPPα)
also occur in the Akt1/PKBα activation/deactivation cycle [103,104,105,106]. In addition to the
role of reversible phosphorylation/dephosphorylation in the regulation of Akt1/PKBα activity,
this kinase is also reversibly inactivated by S-nitrosylation under conditions that result in
persistently increased production of nitric oxide; such as after burn injury [107,108,109,110].
Thiol titration and NMR data indicate that a disulfide bond (Cys60-Cys77) exists in the kinase
PH domain [111]. A second disulfide bond in the critical kinase activation loop (Cys297-Cys311)
has been reported to be associated with dephosphorylation under oxidative stress in vitro[112].
In addition, it has been shown that when Cys224 of Akt1/PKBα is mutated to a Ser residue, the
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kinase becomes resistant to NO donor-induced S-nitrosylation and inactivation; suggesting
that this residue is a major S-nitrosylation acceptor site [109]. In vivoS-nitrosylations of the
insulin receptor (β) and Akt1/PKBα result in reductions in their kinase activities [108]. These
data suggest that the redox status of Akt1/PKBα, regulated by NO, is a second factor in the
post translational modifications that modulate kinase activity (via dynamic conformational
changes) and thus GLUT-4 trafficking and cellular FOXO translocation. Nevertheless, up to
now, published data on the reversible phosphorylation(s) and S-nitrosylation(s) relevant to
Akt1/PKBα activation, conformation and regulation have not provided conclusive information
about their interrelationships nor critical S-nitrosylation sites involved in the kinase activation/
deactivation cycle.
Recent technical developments have made it feasible to study the molecular details of these
important processes. These techniques include: 1. sensitive and site-specific procedures for the
detection of S-nitrosylation based upon NanoLC interfaced with tandem MS/MS; 2. the Biotin-
Switch method for qualitative discrimination of thiol state between free, disulfide bonded and
S-nitroylated cysteine residues under carefully defined conditions [113,114,115,116,117,118];
and 3. highly specific anti-Akt1/PKBαmAb’s that can be used to immunoprecipitate quantities
of the protein that are sufficient to yield SDS-PAGE bands with Coomassie brilliant blue R-250
staining which are compatable with tandem MS analysis.
The following issues need to be taken in considerations: 1. the ability of Cys296 to chemically
quench elevated levels of free radicals, specifically nitric oxide; 2. loop conformational changes
associated with two types of PTM; 3. quantitative proteomics of Akt1/PKBα by stable isotope
labeling in mice. We obtained MS/MS sequence data to characterize the thiol states of Cys296
in the kinase activity loop of Akt1/PKB. These measurements were possible despite the
extremely low level of nitrosylated protein (at the 10-15pmol level, the chance of positive hits
is ~25% with lysates prepared from 25 mg of soleus muscle). The biochemical role of S-
nitrosylation at Cys296 was characterized as an intermediate state which reduces the kinetic
barrier to form the disulfide bond with Cys310 within the activity loop. This occurs simultane‐
ously with dephosphorylation of pThr308 after burn injury. The facts that no other disulfide
bonds associated with Cys296 were detected suggest that they may be thermodynamically
forbidden; due to geometry and/or dihedral angle strain. The data obtained with soleus muscle
from burned and sham treated rats indicates that NO mediated formation of the Cys296-
Cys310 disulfide bond (which likely down-regulates kinase activity) plays a reciprocal role with
formation of a Lys297-pThr308 salt bridge (which up-regulates kinase activity) during disease
associated reversible activation/deactivation processes.
To further the proof-of-concept about formation of a Cys296-Cys310 disulfide bridge after burn
injury, metabolically labeled Akt1/PKBα was characterized with NanoLC-Q-TOF tandem
mass spectrometry based on the classic isotope dilution principle. Akt1/PKBα in liver extracts
from mice with burn injury that were fed with [2H7]-L-Leu was immunoprecipitated and
isolated with SDS-PAGE. Two tryptic peptides, one in the kinase loop and a control peptide
just outside of the loop were sequenced. Their relative isotopologue abundances were
determined by stable isotope labeling by amino acids in mammalians (SILAM)[119]. Relative
quantifications based on paired heavy/light peptides were obtained in 3 steps. 1. Homogeni‐
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zation of mixtures of equal amounts of tissue from burned and sham treated animals (i.e.,
isotope dilution) and acquisition of uncorrected data based on parent monoisotopic MS ion
ratios; 2. Determination of isotopic enrichment of the kinase from burned mice on Day 7; and
3. Enrichment correction of partially labeled heavy and light monoisotopic MS ion ratios for
relative quantification of bioactivity (loop peptide) and expression level (control peptide). Our
data demonstrate that protein synthesis and enrichment after injury were dependent on tissue
and turnover of individual proteins. Three heavy and light monoisotopic ion ratios for albumin
peptides from burned mice indicated ~55% enrichment and ~16.7 fold down regulation. In
contract, serum amyloid P had ~66% enrichment and was significantly up regulated. Akt1/
PKBα had ~56% enrichment and the kinase level in response to burn injury was up regulated
compared with the control peptide. However, kinase bioactivity, represented by the Cys296
peptide, was significantly reduced. Overall, we demonstrate that 1. Quantitative proteomics
can be performed without completely labeled mice; 2. Measurement of enrichment of acyl-
tRNAs is unnecessary and 3. Cys296 plays an important role in kinase activity after burn injury.
Stable isotope labeling by amino acids in cell culture (SILAC) provides relative quantification
of in vitro protein synthesis and functional proteomics under conditions that mimic disease
states [120,121,122,123,124]. Typically, two cell populations are cultured for six doublings
times; control cell medium contains the natural amino acid (e.g., 12C6-Lys and/or 12C6-Arg, 99%
natural abundance), and the second medium contains the same levels of amino acids with
heavy isotopes (e.g., 13C6-Lys and/or 13C6-Arg, 98% abundance) and disease related stimuli. The
two cell populations are mixed with equal amounts of total proteinand digested peptides are
accurately measured by mass spectrometry with a mass difference of 6 Da for singly charged
parent ions. Six doubling times allows isotopic enrichment of the precursor acyl-tRNA pool
to reach ~98% in cancer cell lines. Labeling above 95% is generally required for comparative
and quantitative proteomics by MS. Thus, the relative abundance of any paired peptide’s
monoisotopic MS ion chromatogram with SILAC can be used to measure protein synthesis in
comparison with the controls under in vitro conditions. The SILAC approach has been used
with C. elegansfed with >98% 15N labeled E. coli [125], skeletal muscle from chickens fed with
a synthetic diet containing 50% of [2H8]-Val [126,127], partially labeled rat diet with >99% ape
15N algal cells for 44 days [128] and F1-F4 offspring of mice fed with lysine-free diet containing
1% of L-13C6-Lys [129]. Complete labeling has been reported to be achieved by the F2 genera‐
tion. Metabolic labeling with 15N can be performed efficiently and economically, however, data
interpretation can be challenging since the monoisotopic peak can shift, due to the distribution
of positional isotopomers as a function of labeling time [130,131]. Global labeling with 15N has
been used as a tool for characterization of enrichment under partially labeling conditions
[132,133,134]. Stable isotope labeled amino acids, such as L-13C6-Lys and L-13C6-Arg, provide
ideal residues at C-terminal labeling positions for trypsin digestion. Protein synthesis depends
on 2 factors: acyl-tRNA levels and protein turnover rate. These factors are tissue, cell type, time
and treatment dependent. To minimize individual variability, full incorporation of L-13C6-Lys
can be achieved in mice; however, it is very costly.
Analysis of the hypermetabolic/inflammatory response under acute phase conditions is very
challenging for several reasons: 1. Significant changes in protein expression are associated with
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high levels of reactive oxygen species (ROS) and post translational protein modifications; i.e.
not only protein levels but also biological activities have to be quantified; 2. Individual protein
enrichments and incorporated isotope distributions may vary with the partially isotope
enriched precursor t-RNA pool (>50%) and corresponding protein turnover rates during the
acute phase response.
To address these considerations and explore the feasibility of the basic SILAC approach in
animals under acute phase and partial isotope labeling conditions, a mouse model with full-
thickness 40% TBSA burn was used to proteomically characterize liver Akt1/PKBα|| from the
perspectives of both protein expression and biological activity. [Isopropyl-2H7]-L-Leu was
selected for labeling based on 4 considerations: 1. L-Leu is an essential amino acid with high
abundance in proteins. 2. Compared with other amino acids, [isopropyl-2H7]-L-Leu is rela‐
tively inexpensive; 3. None of the 7 deuterium atoms of [isopropyl-2H7]-L-Leu are attached at
the α-carbon which may be exchangeable with hydrogen atoms; thus in contrast to studies
with [2H10]-Leu, MS offset can be eliminated as a confounding variable; 4. The hydrophobicity
of L-Leu reduces false negative discovery during C18 reversed phase trapping and desalting.
It has been reported that NO production is elevated by stressors such as burn injury and in
patients with type 2 diabetes [110,135,136]. It has also been shown that the Cys297–Cys311
disulfide bond in the critical kinase activation loop of Akt1/PKBα may be formed in association
with dephosphorylation under oxidative stress in vitro [112]. Thus, we hypothesized that
reversible S-nitrosylation at either Cys296 or Cys310 in the kinase active loop may be a PTM factor
which complements reversible phosphorylation at Thr308 in the regulation of kinase activity
and sought to determine how S-nitrosylation interacts with phosphorylation during the Akt1/
PKBα activation cycle [103]. To address these issues, GSNO was used as the only NO donor
in a model S-nitrosylation system to randomly target the seven cysteine residues of the kinase
at pH = 8. The nucleophilic role of sulfhydryl groups is well documented and it is clear that
cysteine residues located in the enzyme hydrophobic loop are important catalytic entities in
both transfer and addition reactions. Vicinal Cys296 and Cys310 take advantage of the pKa for
dissociation of the thiol to thiolate and these electron-rich thiolate groups can lead to formation
of an intradomain disulfide bond [137].Therefore, Cys296 and Cys310 are potential S-nitrosyla‐
tion sites as predicted from the 3D structure of the kinase. NO donors, such as thioredoxin and
thiol/disulfide oxidoreductases were excluded from the system to prevent possible interfer‐
ences [138,139], however, a small amount of 2-mercaptoethanol (~0.05% v/v) was necessary to
prevent oxygen effects.
The simple, but well-defined, S-nitrosylation reaction model was used to probe for particular
NO acceptor sites in human Akt1/PKBα (inactive, 89% pure containing 2-mercaptoethanol and
EGTA, Upstate) in three steps: A. Mapping of all cysteine residues with DTT reduction,
iodoacetyl-LC-Biotin alkylation and affinity capture provided relative MS ionization efficacies
and charge states; B. Detection of disulfide bonds with and without GSNO, provided an
understanding of NO-mediated disulfide bond formation. C. MS/MS pinpointed the S-
nitrosylated sites with three different thiol-specific derivatives. False negatives may occur with
the Biotin-Switch method, whereas false positives are more common with the other methods,
however, thiolether derivatives can be identified with MS/MS data. The findings of these
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studies were used to study the biological consequences of S-nitrosylation of Akt1/PKBα in
soleus muscle from burned rats. This in vivo system was used because soleus muscle is an
insulin sensitive tissue with relatively high levels of IRS-1.
A base peak intensity (BPI) Nano-LC chromatogram of all seven affinity captured cysteine
residues that were biotinylated with iodoacetyl-LC-Biotin is shown in Figure 10A. Cysteine
residue monoisotopic mass of C3H5NOS = 103.01 Da was replaced with derivatizedCys residue
monoisotopic mass of C21H35N5O4S2 = 485.21 Da. The relative simplicity of the NanoLC
Figure 10. Mapping of cysteine residues in inactive Akt1/PKBα (a) Base peak intensity (BPI) NanoLC chromatogram of
affinity capture of all seven cysteine residues that were biotinylated with iodoacetyl-LC-Biotin (b) TOF MS analysis of
parent ions co-eluted at retention time of ~53 min. Parent ions m/z 924.67 and m/z 1386.51 are triply and doubly
charged ions from the same tryptic peptide 308TFCGTPEYLAPEVLEDNDYGR328 which contains Cys310. Parent ion m/z
1266.09 is a triply charged ion from the tryptic peptide, 437YFDEEFTAQMTITPPDQDDSMECVDSER465, which contains
Cys460. Parent ion m/z 815.87 is a doubly charged ion derived from the tryptic peptide, 77CLQWTTVIER86, which con‐
tains Cys77. The parent ion at m/z 1088.49 results from CH4 neutral loss from m/z 1096.46 as shown in Figure 10C. (c)
TOF MS analysis of parent ions co-elutting at retention time of ~50.8 min. Parent ions m/z 731.33 and m/z 1096.46
are triply and doubly charged ions from the same tryptic peptide, 49ESPLNNFSVAQCQLMK64, which contains Cys60. Pa‐
rent ion m/z 639.79 is doubly charged and is derived from tryptic peptide, 290ITDFGLCK297, which contains Cys296. (d)
TOF MS analysis of parent ions co-eluting at retention time of ~53.5 min. Parent ion m/z 829.00 is triply charged and
derived from tryptic peptide, 329AVDWWGLGVVMYEMMCGR346, which contains Cys344. Parent ion m/z 872.70 is triply
charged and derived from tryptic peptide, 223LCFVMEYANGGELFFHLSR241, which contains Cys224.
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chromatogram indicates the high purification efficacy for removing non-biotinylatedtryptic
peptides from streptavidin agarose beads. Three predominate TOF MS tryptic parent ions were
identified; m/z 639.81 (T41, M+2H+ = 639.83) eluting at 50.5 min, m/z 1088.49 (T9, M-CH4+2H+
= 1088.03) at eluting at 51.5 min and m/z 924.67 (T44, M+3H+ = 924.43) eluting at 53 min are
doubly and triply charged tryptic peptides containing Cys296, Cys310 and Cys60, respectively.
Figure 10B shows the parent ions co-eluting at ~ 53 min as well as the charge state assignments.
Parent ions m/z 924.67 (T44, M+3H+ = 924.43) and m/z 1386.51 (T44, M+2H+ = 1386.14) are triply
and doubly charged ions from the same tryptic peptide, 308TFCGTPEYLAPEVLEDNDYGR328,
which contains Cys310. Parent ion m/z 1266.09 (T58, M+3H+ =1266.41) is triply charged and
derived from the peptide, 437YFDEEFTAQMTITPPDQDDSMECVDSER465, which contains
Cys460. Parent ion m/z 815.87 (T11, M+2H+ = 815.93) is doubly charged from the peptide,
77CLQWTTVIER86, which contains Cys77. Parent ion m/z 1088.49 resulted from CH4 neutral loss
from m/z 1096.48. Figure 10C shows TOF MS parent ions that co-eluted at ~50.8 min; chroma‐
tographic peak tailing the most intense peak at 50.5 min. Parent ions m/z 731.33 (T9, M+3H+ =
731.03) and m/z 1096.46 (T9, M+2H+ = 1096.04) are triply and doubly charged ions from the
same tryptic peptide, 49ESPLNNFSVAQCQLMK64, which contains Cys60. Parent ion m/z 639.81
(T41, M+2H+ =639.83) is a doubly charged ion from the tryptic peptide, 290ITDFGLCK297, which
contains Cys296. Figure 10D shows the TOF MS parent ions that co-eluted at ~53.5 min. Parent
ion m/z 829.00 (T45, M+3H+ = 829.05) is triply charged and derived from the tryptic peptide,
329AVDWWGLGVVMYEMMCGR346, which contains Cys344. Parent ion m/z 872.70 (T32, M+3H
+ = 872.43) is triply charged and derived from the tryptic peptide, 223LCFVMEYANG‐
GELFFHLSR241, which contains Cys224. No doubly charged T58, T45 or T32 ions were observed.
It is clear that the ionization efficacies for the peptides containing Cys296 (M+2H+), Cys310 (M
+2H+ and M+3H+), Cys60 (M+2H+ and M+3H+) and Cys77 (M+2H+) are much higher than for the
triply charged peptides containing Cys460 (M+3H+), Cys334 (M+3H+) and Cys224 (M+3H+) under
the same conditions.
When Akt1/PKBα was treated with GSNO without cleavage of disulfide bonds and the free
cysteine residues were alkylated with iodoacetamide, two intradomain disulfide bonds were
identified: Cys60-Cys77 in the PH domain and Cys296-Cys310 in the kinase active loop.
The monoisotopic parent ion with m/z = 821.35, shown in Figure 11A, represents two tryptic
peptides containing the Cys296-Cys310 disulfide bond in the kinase loop. The isotopic peaks at
m/z 821.61 and m/z 821.35 are attributed to the M + 1 and M + 0 ions. A mass difference of 0.26
Da (expected 0.25 Da) indicated 4 positive charges: two at n-terminals and two at side chains
of the c-terminals of the dipeptides. The expected quadruply charged disulfide bond linked
Cys296 and Cys310 containing peptides (T41-SS-T44, M + 4H+) were calculated to be m/z 821.38
[(894.45 + 2387.06 + 4)/4]. The monoisotopic parent ion with m/z = 764.41, shown in Figure
11B, represents the two tryptic peptides containing the Cys60-Cys77 disulfide bond in the PH
domain. The quadruply charged state is calculated as m/z 764.66 (M + 1) – 764.41 (M + 0) = 0.25
which indicates 4 positive proton charges. The quadruply charged disulfide bond linked
Cys60 and Cys77 containing peptides (T9-SS-T11, M + 4H+) are calculated as m/z 764.37 [(1806.86
+ 1246.63 + 4)/4]. Without GSNO treatment, only the Cys60-Cys77 disulfide bond was detected.
The mass accuracies for the two measurements were found to be 36 ppm (Cys296-Cys310
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 disulfide bond linked dipeptides) and 78 ppm (Cys60-Cys77 disulfide bond linked dipeptides).
The impact of GSNO on Cys296-Cys310 disulfide bond formation is demonstrated in Figure 11C
and D. The S-nitrosylation reaction without GSNO (Figure 11C) shows the triply charged
tryptic peptide, 308TFCGTPEYLAPEVLEDNDYGR328, (CAM derivative) containing Cys310 at
m/z 815.99 (expected monoisotopic parent ion: 816.03). The observed M+1 isotopic peak was
at m/z 816.33. The difference between the isotopic M+1 and M+0 peak of 0.34 Da indicates 3
Figure 11. Detections of two intradomain disulfide bonds in Akt1/PKBα (a) Detection of intradomain Cys296-Cys310 di‐
sulfide bond in the kinase loop. Inactive Akt1/PKBα (10 μg) was treated with GSNO and iodoacetamide (50 μM) in
Laemmli sample buffer. In-gel trypsin digestion was performed after SDS-PAGE separation (BIO-RAD, 4-15% Tris-HCl).
Monoisotopic parent ion at m/z 821.35, charge state: 4. Expected quadruply charged disulfide linked Cys296 and Cys310
containing the peptide at m/z 821.38. (b) Detection of the intradomain Cys60-Cys77 disulfide bond in the PH domain.
Monoisotopic parent ion at m/z 764.41, charge state: 4. Expected quadruply charged disulfide bond linked Cys60 and
Cys77 containing peptide at m/z 764.37. (c) Free thiol state of Cys310 in the kinase loop without NO donor. The triply
charged parent ion m/z 815.99: 308TFCGTPEYLAPEVLEDNDYGR328 (expected: m/z 816.03, carboxyamidomethylcys‐
teine, CAM derivative) represents the completely free thiol state of Cys310, while the triply charged m/z 821.31 is not
from disulfide linked Cys296-Cys310 dipeptides (expected charge state: 4). The Cys296-Cys310 disulfide bond was not de‐
tected in the absence of NO donor. (d) Nitric oxide promotes the formation of the Cys296-Cys310 disulfide bond in the
kinase loop. Inactive Akt1/PKBα (10 μg) was treated with GSNO (250 nmol, 50 μl PBS, pH = 8.0, 1 hr at room tempera‐
ture in the dark) prior to alkylation with iodoacetamide and SDS-PAGE. The doubly charged m/z 816.35 ion is not
from a Cys310 containing tryptic peptide (expected charge state: 3), and quadruply charged m/z 821.33 occurs at the
expense of diminished triply charged Cys310 peptide. The free thiol of Cys310 is completely converted into the disulfide
bond with Cys296.
Tandem Mass Spectrometry - Molecular Characterization162
proton charges. In contrast, the triply charged ions at m/z 821.31 and m/z 821.65 (difference =
0.31 Da) do not represent the quadruply charged Cys296-Cys310 dipeptides in Figure 11C. The
triply charged Cys310 containing peptide was found to be totally absentwith GSNO treatment
as shown in Figure 11D. The doubly charged ions at m/z 816.35 and m/z 816.85 (difference =
0.50 Da) are not related to the triply charged tryptic peptide 308TFCGTPEYLAPEVLEDN‐
DYGR328 (CAM derivative) containing Cys310 at m/z 815.99 as shown in Figure 11C. In contrast,
the ions at m/z 821.33 and m/z 821.58 (difference = 0.25 Da) are indeed from quadruply charged
Cys296-Cys310 linked dipeptides. Since quadruply charged Cys296-Cys310 linked dipeptides are
formed at the expense of triply charged Cys310 containing peptide after GSNO treatment, it is
obvious that S-nitrosylation and disulfide bond formation occur simultaneously in the kinase
loop.
We next sought to determine which cysteine residue is the NO acceptor that initializes Cys296-
Cys310 disulfide bond formation. There are three possibilities for the two cysteine residue thiol
states: single S-nitrosothiol, double S-nitrosothiols and nitroxyl disulfide. The last case
(nitroxyl disulfide) can be ruled out from the list, since expected net mass increases of 28 Da
(NO - 2H = 30 - 2 Da) were not observed for the corresponding dipeptides. The second case,
double S-nitrosothiols of Cys296 and Cys310, may occur if both pKa’s are acidic inside the kinase
loop. The Biotin-Switch method was used to identify the S-nitrosothiol within the loop under
gentle reaction conditions (GSNO 250 nmol, 1 hour). In addition, two other thiol-specific
reagents, iodoacetic acid and iodoacetyl-LC-Biotin (leaving molecule: HI, fast and quantita‐
tive), were evaluated.
Chem derivatives Parent calc. Parent found y2 ion calc. y2 ion found
CMC 953.45 953.42 308.13 308.17
HPDP-Biotin 1323.64 1323.68 678.32 678.29
Acetyl-LC-Biotin 1277.65 1277.58 632.33 632.38
Table 3. Characterization of the thiol-specifically modified Akt1/PKBαpeptide 290ITDFGLCK297
Confirmations of the S-nitrosylation sites were performed by the following 3 step procedure:
A. Parent ion discoveries with automated data dependent acquisition (DDA); the peptide mass
tolerance was 0.2 Da for the carboxymethyl cysteine (CMC) immonium ion. Under these
conditions, only a few false positive ions were observed and these were eliminated manually
from the expected CMC parent ion list. B. Confidently discovered parent ions were analyzed
with PepSeq of MassLynx V4.1 software; oxidation of methionine was searched as a variable
modification. C. For peptides, with MS/MS scores < 35, manual interpretations of candidate
parent ions were performed with the following procedure: continuum MS/MS spectra were
smoothed, the upper 80% was centroided and cysteine residues were confirmed with three
different thiol-specifically derivatized y ions. Cysteine residue monoisotopic mass C3H5NOS
= 103.01 Da was replaced with CMC residue monoisotopic mass C5H7NO3S = 161.01 Da, HPDP-
Biotin derivatized adduct residue monoisotopic mass C22H37N5O4S3 = 531.20 Da and iodoacetyl-
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LC-Biotin derivatized adduct residue monoisotopic mass C21H35N5O4S2 = 485.21 Da,
respectively.
Table 3 shows the expected results of Cys296S-nitrosylation in the kinase loop with the three
different chemical modifications. The resulting S-nitrosylatedCys was reduced with ascorbate
and then derivatized with iodoacetic acid to afford the CMC derivative (the Cys residue with
a monoisotopic mass C3H5NOS = 103.01 Da was replaced by the CMC residue with a monoi‐
sotopic mass C5H7NO3S = 161.01 Da) for sequence analysis. The CMC derivative of the y2 ion
of the doubly charged tryptic peptide, 290ITDFGLCK297, was confirmed at m/z 308.17 (expected
308.13 = 161.01 + 145.10 +2.02). The Cys HPDP-Biotin adduct (Cys residue monoisotopic mass
C3H5NOS = 103.01 Da was replaced with the adduct residue monoisotopic mass C22H37N5O4S3
= 531.20 Da) was used for sequence analysis. The corresponding y2 ion of the Biotin-HPDP
derivatized, 290ITDFGLCK297, was confirmed at m/z 678.29 (expected 678.32 = 531.20 + 145.10
+2.02). The CysIodoacetyl-LC-Biotin adduct (Cys residue monoisotopic mass C3H5NOS =
103.01 Da was replaced with adduct residue monoisotopic mass C21H35N5O4S2 = 485.21 Da) was
used for peptide sequence analysis. The corresponding y2 ion of iodoacetyl-LC-Biotin
derivatized, 290ITDFGLCK297 was confirmed at m/z 632.38 (expected 632.33 = 485.21 + 145.10
+2.02). Since the y2 ions of 296Cys-Lys297 produced with the three different derivatization
procedures were unambiguously observed it is likely that Cys296 is a favorable S-nitrosylation
site under the conditions used. Although studies with mutated Akt1/PKBα|| (C224S) indicated
that Cys224 is a major S-nitrosylation acceptor site in vitro, the biological role of S-nitrosylated
Cys224 in kinase regulation needs to be further explored. In the current study it was determined
that significant S-nitrosylation of Cys224 is improbable, since using the three alkylation
approaches and trypsin digestion, the levels of positive ionization of Cys224 containing peptides
were below the level of detection. This failure in detection of S-nitrosylated Cys224 might be a
false negative under our experimental conditions and clearly warrants further investigation.
Nevertheless, our findings clearly demonstrate that S-nitrosylated Cys296 is directly relevant
to the kinase activation regulation cycle.
One possible explanation for the kinetics of Cys296-Cys310 disulfide bond formation in the kinase
loop may be that there is a high kinetic barrier without GSNO. Due to its highly labile nature
[140], S-nitrosylated Cys296, which forms rapidly in the presence GSNO, may function as an
intermediate state. Since this intermediate is likely to have a lower kinetic barrier for Cys296-
Cys310 disulfide bond formation, the overall speed of the reaction should increase greatly. It
has been reported that trans-nitrosylation reactions between vicinal thiols can occur and
accelerate disulfide bond formation [141]. The well characterized Cys296-Cys310 disulfide bond
can be used as a signature peptide for detection of S-nitrosylation of Cys296 after immunopre‐
cipitation. The separation of tryptic peptide mixtures with our NanoLC interfaced Q-TOF is
demonstrated in Figure 12 (bottom panel). The extracted mass ion peak m/z 821.62, as shown
in Figure 12 (top panel), is the M+1 isotopic peak of the quadruply charged dipeptides (the
most intense isotopic peak due to high number of carbon atoms).
The in vitro system allowed us to determine conditions that are favorable for evaluation of S-
nitrosylation of Cys296 by MS/MS and was useful for studying the mechanism of intradomain
disulfide bond formation. The reason for using inactive Akt1/PKBα (unphosphorylated) in
these studies was to find possible S-nitrosylation sites in relationship with the following
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published data: 1. Akt1/PKBα undergoes transient phosphorylation/ dephosphorylation
which regulates the kinase activity conformation cycle; 2. Kinase disulfide bond formation,
Cys297-Cys311, and dephosphorylation at pThr308 are induced simultaneously by H2O2 oxidative
stress in vitro; 3. High levels of nitric oxide production occur both after burn injury and in
diabetic patients. Previous results from our laboratory have indicated that there is S-nitrosy‐
lation at Cys296 in rat soleus muscle. A parention at m/z 690.83 containing Cys296 (T41-T42:
290ITCFGLCKEGIK301) was observed with CAM immonium trigged parent ion discovery,
however, MS/MS sequencing data was not obtained. As a continuation of these studies to
explore S-nitrosylation in the kinase active loop, large amounts of rat soleus muscle lysate (~
3-5 mg/ml total proteins, 3 ml for each experiment, day 4 after 40% TBSA, 3rd degree burn)
were used. In the present study, detailed MS/MS analysis of HPDP-biotinated free Cys296
peptide and Cys296-Cys310 disulfide bound dipeptides of Akt1/PKBα were performed with
lysates of rat soleus muscle after burn injury. The tryptic parent ion derivatized from free
Cys296 after burn injury was observed at m/z 662.84 (M+2H+, expected 662.82) and the MS/MS
sequence data is shown in Figure 13. A low sequence score of 18 was obtained from the parent
ion with S/N = 3. However, the critical diagnostic y2, y4 and y5 ions at m/z 678.29, m/z 849.34
and m/z 995.51 confirmed that trace amounts of free Cys296 are indeed present after intrado‐
Figure 12. NanoLC chromatogram of tryptic peptides of Akt1/PKBα in soleus muscle Top panel: Mass ion chromato‐
gram of the dipeptides m/z 821.62: M+1 isotopic peak of the quadruply charged dipeptides (intensity of M+0 monoi‐
sotopic peak is lower than M+1 due to isotope abundant as shown in Figure 11A). Bottom panel: BPI chromatogram
of the Akt1/PKBαtryptic peptides after immunoprecipitations and in-gel digestion from NanoLC interfaced with Q-
TOF tandem mass spectrometry.
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main disulfide bond formation induced by burn injury. In addition, partial sequencing data
for Cys296-Cys310 disulfide linked dipeptides is shown in Figure 14.
The phosphorylation status of Akt1 Thr308 and Ser473 were evaluated by ELISA and the results
were expressed as units per gram tissues. Figure 15 shows that phosphorylations of Akt1 at
Thr308 and Ser473 in skeletal muscle of burned mice were reduced by 49.8% (p<0.005) and 26.2%
(p<0.05) compared with sham treated control animals.
The C-terminal y ion series of Cys310 containing peptide, 308TFCGTPEYLAPEVLEDNDYGR328,
was observed for the quadruply charged parent ion (T41-SS-T44, M + 4H+). Cys296-Cys310
disulfide linked dipeptides were not observed in muscle lysates from sham treated animals.
The chance of obtaining the MS/MS sequence using our in vivo experimental conditions is only
about 20-25%. This indicates that one interpretable MS/MS outcome (score > 25) is expected in
4 or 5 independent experiments in which 3 successive injections are performed. Nevertheless,
these MS/MS data for peptides containing free Cys296 and Cys296-Cys310 linked dipeptides are
sufficient to verify our hypothesis that S-nitrosylation promotes intradomain disulfide bond
formation and dephosphorylation at pThr308 after burn injury as illustrated in Figure 16. Due
to the high lability of Cys296-SNO,direct identification of this species in vivo was not possible.
Figure 13. Sequence analysis of biotinated free Cys296 peptide of Akt1/PKBα after burn injury Rat soleus muscle lysates
(30 mg total protein) were treated with anti-Akt1/PKBαmAb and in-gel biotination was performed with HPDP-Biotin.
Parent ion m/z 662.84 (M+2H+, expected 662.82) was sequenced. Cys residue monoisotopic mass C3H5NOS = 103.01
Da is replaced with the adduct residue monoisotopic mass C22H37N5O4S3 = 531.20 Da. A low sequence score of 18 was
obtained from the parent ion with S/N = 3, however the critical diagnostic y2, y4 and y5 ions at m/z 678.29, 849.34
and 995.51 confirmed that trace amounts of free Cys296 are presentafterburn injury.
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Proposed mechanism for burn-induced Akt1/PKBα kinase loop conformational changes via
phosphorylation and S-nitrosylation cross-taking in skeletal muscle. Phosphorylation of
Thr308 stabilizes the disordered loop structure between 292DFG and APE319 via a salt bridge with
Lys297 as illustrated in the loop peptide 1, which up-regulates Akt1/PKBα kinase activity. NO
free radical production is increased after burn injury, consequently, a large portion of Cys296
undergoes S-nitrosylation at Cys296 (peptide 2), however, some free Cys296 remains, which can
be biotinylated for MS/MS confirmation (peptide 3). S-nitrosylation activates Cys296-
Cys310intradomain disulfide bond formation (peptide 4). S-nitrosylation at Cys296 is associated
with dephosphorylation of Thr308 and inaccessibility to the kinase site as shown in Akt1 crystal
structure [142]; which down-regulates kinase activity.
S-nitrosylation of Akt1/PKBα is a key factor for understanding the regulation of glucose
transport and downstream protein synthesis. A recent report demonstrated that blockade of
iNOS prevents the S-nitrosylations of Akt and IRS-1 and results in insulin resistance in vivo
[143]. Although it is clear that two PTMs of Akt1/PKBα, phosphorylation at Thr308 and S-
nitrosylation at Cys296, are critical for the regulation of Akt1/PKBα activity under stress
conditions, there are still many unanswered questions concerning how reversible phosphor‐
ylation/ dephosphorylation and S-nitrosylation/denitrosylation modulate Akt1/PKBα activity.
Figure 14. Identification of the Cys296-Cys310 disulfide linked peptide with dephosphoryated Thr308 in soleus muscle
from burned rats MS/MS sequence of Cys296-Cys310 disulfide linked dipeptides: C-terminal y ion series (y3 to y9) of
Cys310 containing peptide, 308TFCGTPEYLAPEVLEDNDYGR328, were observed from the quadruply charged parent ion
(T41-SS-T44, M + 4H+).
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For example, it has been reported that the Cys296-Cys310 disulfide bond is present only when
there is binding of substrate to the active kinase loop and phosphorylation at Thr308; indicating
that both disulfide bond formation as well as phosphorylation of Thr308 are important for kinase
activity. In contrast, this disulfide bond was not observed under similar conditions in two
studies of the ternary structure of the kinase; even though, oxidative stress was shown to
induce dephosphorylation of pThr308 and disulfide bond formation in the kinase loop in an in
vitro study [112].
In summary, our data establishes that Cys296 is an important S-nitrosylation site in the kinase
loop of Akt1/PKBα under gentle reaction conditions: (a) iodoacetic acid as previously descri‐
bed; (b) the HPDP-Biotin switch method and (c) the iodoacetyl-LC-Biotin method to ensure
indirect capture of Cys296-SNO which may be undetectable with HPDP-Biotin. The corre‐
sponding derivatized y2 ions (296Cys-Lys297) in the tryptic peptide (Ile-Thr-Asp-Phe-Gly-Leu-
Cys-Lys) were obtained with mass sequences to eliminate false positive discovery. Although
no other S-nitrosylated cysteine residues were detected, it is possible that S-nitrosylations at
Cys224, Cys344 and Cys460 were missed due to very low ionizations (i.e., false negative discov‐
eries). As a consequence of S-nitrosylation at Cys296, there is rapid disulfide bond formation
with vicinal Cys310 in the kinase loop. This affords a stable disulfide bond linked quadruply
charged parent ion at m/z 821.35 (M + 4H+). Partial sequencing data for Cys296-Cys310 linked
dipeptides from soleus muscle lysates indicated that burn injury is associated with bothde‐
phorsphorylation of pThr308 and disulfidebond formation. Current qualitative results have
Figure 15. Impaired phosphorylation of Thr308 and Ser473 of Akt1 in skeletal muscle of burned mice. Skeletal muscle
tissues from burned mice were homogenized with Cell Signaling buffer and phosphorylation levels of Thr308 and Ser473
in Akt1 were measured by ELISA. Akt pThr308 ELISA kit (KHO0201) and pSer473 kit (KHO0111) were purchased from
Invitrogen. The phosphorylation units were normalized to tissue weight. Values represent mean ± sem for 15 burned
and 8 sham treated mice. *: p<0.05, **: p<0.005.
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provided important mechanistic information; however, quantitative measurements of
Cys296thiol states post-burn injury remain very challenging.
The essential issue for any isotope dilution method is to precisely characterize the heavy
isotope labeled internal standard in terms of atomic and chemical purities. To determine the
relative quantification of liver Akt1/PKBα after burn injury, two typical serum acute phase
proteins, negative regulated albumin and positive regulated amyloid P component, as well as
liver Akt1/PKBα were characterized in a preliminary study with tissue and blood samples
from 3 mice with burn injury (40% TBSA). To eliminate possible mathematical and biological
complexities associated with of multiple isotopomer population distributions for individual
tryptic peptides produced with partial labeling conditions, peptides with only one instance of
[isopropyl-2H7]-L-Leu were selected for measurement of relative labeling efficiencies. A tryptic
peptide may be positively charged at its N-terminal α-amine group and the side-chain amine
group of a Lys residue or the guanido group of an Arg residue; thus, a doubly charged parent
ion, [M + 2H+], may be observed with ESI mass spectrometry. In addition, triply charged tryptic
parent ions, [M+3H+], may be obtained for peptides containing proline or histidine residues or
with larger size peptides. Peptides with one instance of [isopropyl-2H7]-L-Leuincorporation
yield paired light and heavy parent ions with monoisotopic mass ion differences of 3.5 Da
(doubly charged) or 2.3 Da (triply charged) under ESI conditions. Charge state dependent DDA
Figure 16.
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allows these multiply charged peptides to be focused in the CID chamber with charged argon
cleavages. The singly charged and predominated light and heavy MS/MS y ion series from the
light and heavy parent ions are produced with mass difference of 7 Da. This allows unambig‐
uous relative quantification of parent ion enrichments from possible false positive discoveries.
Characteristics of three proteins with enrichments of greater than 50% are shown in Table 4.
Sequence, (charge state observed) Enrichments %, (SD)
albumin
243LSQTFPNADFAEITK257, (2)
559HKPKATAEQLK669, (2)
439APQVSTPTLVEAAR452, (2)
53 (3.2)
57 (3.8)
54 (4.1)
amyloid P component
66SQSLFSYSVK75, (2)
88VGEYSLYIGQSK99, (2)
147APPSIVLGQEQDNYGGGFQR166, (3)
66 (4.9)
65 (4.6)
69 (5.2)
liver Akt1/PKBα
9EGWLHKR15, (2)
184EVIVAKDEVAHTLTENR200, (3)
290ITDFGLB*KEGIKDGATMK307, (3)
59 (4.0)
56 (2.7)
55 (3.3)
Table 4. Protein enrichment levels on day 7 after 3rd degree burn of 40% TBSA
The negative acute phase protein albumin and the positive acute phase protein amyloid P
component had enrichments of ~55% and ~66%, respectively. The enrichment level (56%) of
liver Akt1/PKBα was found to very similar to that of albumin. These enrichment values
represent ultimate [isopropyl-2H7]-L-Leuincorporation in each individual protein which can
be used as the isotopic correction factor for the light and heavy parent ion MS ratio obtained
by mixing exact the same weight of labeled and non-labeled liver tissues.
Akt1/PKBα was immunoprecipitated from the mixture of [isopropyl-2H7]-L-leucine labeled
liver from burned mice an equal amount tissue from sham treated animals and processed
further by the methods described above. The relative expression of Akt1/PKBα at the protein
level from livers of burned and sham treated mice is shown in Figure 17.
The triply charged monoisotopic parent ion at m/z 647.99 was detected for the control peptide
252FYGAEIVSALDYLHSEK268; calculated [M+3H+] = 647.99. Two heavy monoisotopic parent
ions at m/z 650.34 and m/z 652.36 indicates one and two instances of [isopropyl-2H7]-L-Leu
incorporation into the control peptide. Triply charged MS differences were found to be 2.3 Da
(calculated MS difference for one heavy Leu incorporation: 7/3 = 2.3 Da) and 4.3 Da (calculated
MS difference for two heavy Leu incorporation: 14/3 = 4.6 Da), respectively. MS/MS y ion series
from y3 to y12 of the m/z 647.98 confirms the control peptide for studying protein expression.
The intensities of the m/z 650.34 and m/z 652.36 ions represent the heavy Akt1/PKBα popula‐
tions from burn injured mice, whereas the m/z 647.99 ion is derived from the sham treated
animals. Estimated total ion intensity was ~9.5 after burn injury and ~6.5 after sham treatment.
Due to the low S/N of ~2 for the heavy ions and the enrichment of 56% in Table 1, Akt1/
PKBα protein expression, was observed to be up-regulated in response to burn injury the
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mice.However, the heavy ion for the biotinylated peptide, 290ITDFGLCK297, which was used
as a marker for kinase activity, was significantly reduced (almost to background) after injury
as illustrated in Figure 18.
Biotinylated light peptides 290ITDFGLCK297 of Akt1/PKBα from sham treated mice was
detected at m/z 639.88 and was doubly charged as indicated by the natural abundance carbon
isotope peak at m/z 640.33. Three biotinylated y2, y4 and y6 ions at m/z 632.44, 802.51 and
1064.59 confirmed the loop peptide sequence with biotin modification as shown in Figure 19.
The corresponding y2 ion of iodoacetyl-LC-Biotin derivatized, 296CK297, was confirmed at m/z
632.44 (expected 632.33 = 485.21 + 145.10 +2.02). DDA with low S/N occurred in vivo studies
was performed with continuum mode to enhance the parent ion discovery. On the other hand,
centroided spectra are found to be necessary to obtain accurately the diagnostic modifications
in the y ions. Biotinylated heavy peptide 290ITDFGLCK297 in Akt1/PKBα from burn injured mice
(n = 3) was identified at m/z 643.38 with its natural carbon isotopic peak at m/z 643.88. A MS
Figure 17. Changes in liver Akt1/PKBα expression at protein level after burn injury A triply charged monoisotopic pa‐
rent ion at m/z 647.99 was found for the control peptide 252FYGAEIVSALDYLHSEK268; calculated [M+3H+] = 647.99.
Two heavy monoisotopic parent ions at m/z 650.34 and m/z 652.36 indicate one and two instances of [isoprop‐
yl-2H7]-L-Leu incorporation into the control peptide. Akt1/PKBα protein expression, estimated from both heavy ions,
was found to be up regulated after correction for both enrichment and background.
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difference of 3.5 Da between the paired light and heavy parent ions clearly indicated that one
instance of [isopropyl-2H7]-L-Leu was incorporation into the doubly charged parent ion at m/
z 643.38 with doubly charged state (n = 3). MS ion intensity at m/z 643.38 indicated that loop
peptide containing Cys296 was almost undetectable after burn injury. These observations were
evaluated with MS/MS sequencing; peptide charge status and MS shift of the isotope labeled
paired peptides in vivo.
The incorporation efficiencies of isotopically labeled peptides in Table 3 demonstrates that
amyloid P component was 10% higher than albumin; suggesting a faster turnover rate during
up regulation. Serum albumin and liver Akt1/PKBα appear to have similar enrichments ~55%.
Classically, individual protein fractional synthesis rate (FRS) is calculated by the relative isotope
enrichment ratio of the labeled protein vs. precursor acyl-tRNA over the labeling time period
Figure 18. Liver Akt1/PKBα activity measurement via the loop peptide Light peptide, 290ITDFGLCK297, of Akt1/PKBα
from sham treated mice was detected at m/z 639.88; doubly charged as indicated by the natural abundance carbon
isotope peak at m/z 640.33. Biotinylated heavy peptides 290ITDFGLCK297 of Akt1/PKBα from the burn injured mice
were detected at m/z 643.38; doubly charged as indicated by the natural abundance carbon isotope peak at m/z
643.88. The MS difference of 3.5 Da between the paired light and heavy parent ions indicates one instance of [iso‐
propyl-2H7]-L-Leu incorporation into the heavy ion at m/z 643.38 after burn injury. The intensity of the m/z 643.38 ion
indicates that the loop peptide containing Cys296 was markedly reduced (almost to baseline) in response to burn injury
(n = 3).
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for a given isotope tracer [144,145]. FSR is a very important parameter for assessing effects of
clinical  interventions  by comparisons between patients  and healthy controls.  In  general,
information about protein synthesis obtained with FRS and partially labeled SILAM are very
similar and either can be used to optimize therapeutic strategies.
Our previous studies with thermally injured rats have demonstrated that there is no apparent
alteration in binding of insulin to its receptors in liver, skeletal muscle or adipose tissue. Thus,
acute and chronic insulin resistances induced by surgical trauma, burn injury, hemorrhage
and sepsis are primarily post-receptor effects in the insulin-like growth factor-phosphatidyli‐
nositol-3 kinase-Akt pathway. Phosphorylations of specific Ser and Thr residues in the C-
terminus of IRS-1 induce its degradation via the ubiquitin-proteosome pathway; which may
early biological effect after receptor binding. Impaired Akt1/PKBα kinase activity after injury
may be a later downstream event. Deficiency of Akt1/PKBα causes decreased somatic cell and
body size [146], while knockout of Akt2/PKBα leads to insulin resistance [147]. Akt1/PKBα is
involved in cellular survival pathways, by inhibiting apoptotic processes and stimulating
protein synthesis pathways. It is also a key signaling protein in cellular pathways of skeletal
Figure 19. Identification of the kinase loop peptide derivatized with the iodoacetyl-LC-Biotin Cysteine residue monoi‐
sotopic mass C3H5NOS = 103.01 Da was replaced with the iodoacetyl-LC-Biotin derivatized adduct monoisotopic mass
C21H35N5O4S2 = 485.21 Da. Three biotinylated y2, y4 and y6 ions at m/z 632.44, 802.51 and 1064.59 unambiguously
confirmed the loop peptide sequence with biotinylated mass shifts for kinase bioactivity measurements.
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muscle differentiation [148,149]. Currently, assays of Akt1/PKBα|| activity in vitro and in vivo
are performed with antibodies specific for the phosphorylated Ser473 and Thr308 residues which
are critical for stabilizing the global and loop active conformations of the kinase. Difficulties
with using anti-phospho-serine, but not anti-phospho-tyrosine antibodies, have been occurred
in our phosphoproteomic research. NO production is elevated after burn injury and in patients
with type 2 diabetic and it has been shown that the Cys297-Cys311 disulfide bond in the kinase
loop may be formed in association with dephosphorylation under oxidative stress in vitro.
Reversible S-nitrosylation at Cys296 in the kinase loop is another PTM which complements
reversible phosphorylation at Thr308in the regulation of kinase activity. It has been shown that
Akt1/PKBα undergoes transient phosphorylation/dephosphorylation which regulates the
kinase active conformation cycle; kinase disulfide bond formation, Cys297-Cys311, and dephos‐
phorylation at pThr308 are induced simultaneously by H2O2 oxidative stress in vitro [46];and
high levels of nitric oxide production occurs in both burn injured rats and diabetic patients.
Freethiol group of Cys296 undergoes loop conformational changes by capture of nitric oxide,
or chemical modifications with other reactive oxygen species produced under the burn injury;
thus blocking substrate recognition. Intact loop peptide with a trace amount of free cysteine
in the peptide population, 290ITDFGLCK297, after burn injury was developed as an unambigu‐
ous index for bioactivity. However, this peptide is not related to kinase protein expression in
responses to the burn, since varying degrees of different thiol modifications in the loop may
occur at the same time. In contrast, the control peptide, 252FYGAEIVSALDYLHSEK268, loca‐
tedjust outside of kinase loop, was a useful index of protein level. Kinase bioactivity measured
with tandem mass spectrometry was comparable with previously reported data measured
with immune complex kinase assay and anti-pThr308 as well as anti-Ser437mAbs, whereas
protein levels were slightly increased in responses to injury. MS/MS sequence analysis and
[isopropyl-2H7]-L-Leu incorporation in the paired peptides indicated that after thermal injury
kinase activity is significantly reduced, despite increased protein expression. These findings
indicate that neither complete labeling of nor measurement of acyl-tRNA enrichment are
necessary or critical for quantitative proteomics with SILAM. Cys296thiol state is considered as
one of the important factors for the kinase activity. The limitations of partially labeled SILAM
for clinical studies are: 1. Specific protein enrichment must be measured in tissues labeled with
heavy isotopes under stress conditions; unfortunately, many proteins of clinical interest occur
at low abundance and thus there is a high rate of false negative discovery. 2. Sequence
confirmation of individual proteins requires that SDS-PAGE bands be visible by Coomassie
brilliant blue R-250 staining (at least 0.1 μg). Despite these limitations our observations may
provide new insights into the treatment of muscle wasting and other aspects of insulin
resistance after critical injury.
As the central mediator of the IR/IRS/ PI3K/FOXO pathway, Akt1/PKBα kinase loop confor‐
mational changes are induced via a transition from the physiological salt bridge Lys297-Ser308
and the pathphsiological disulfide bond Cys296-Cys310, which inhibits kinase substrate recog‐
nition. Impaired Akt1/PKBα kinase activity and enhancement of the activities of other stress
kinases leads to FOXO3 translocation from the cytosolic compartment into the nuclear
compartment, where FOXO3 transcriptional activity is further regulated by reversible
acetylation.
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4.3. Acetylation of transcription factor FOXO3 in muscle wasting post-burn injury
Skeletal muscle serves as the major protein reservoir from which amino acids can be mobilized
for gluconeogenesis, new protein synthesis or as an energy source. With starvation and in
many systemic disease states, including sepsis, cancer, burn injury, diabetes, cardiac and renal
failure, there is generalized muscle wasting, which results primarily from increased break‐
down of muscle proteins combined with reduced protein synthesis in most of these conditions
[150,151]. In all these catabolic states, the loss of muscle mass involves a common pattern of
transcriptional responses, including induction of genes for protein degradation and decreased
expression of genes for growth-related and energy-yielding processes [152]. In atrophying
muscles, two independent degradation pathways, lysosomal autophagy and proteasomal
proteolysis are activated to catalyze the degradation of muscle proteins, including myofibrillar
components and organelles [153,154,155,156,157,158]. Recent findings suggest that FOXO1 is
a major regulator of energy metabolism in general (159) while FOXO3 may play significant
roles in skeletal muscle wasting in responses to stresses [160,161,162,163,164].
FOXO3 activity is highly regulated by post-translational modifications, including phosphor‐
ylation, acetylation and ubiquitination in response to oxidative stress
[165,166,167,168,169,170]. Under physiological conditions, insulin induces FOXO3 phosphor‐
ylation in muscle via IGF-1/insulin-IRS-PI3K-Akt, leading to the exclusion of FOXO3 from the
nucleus and binding with 14-3-3γ protein. Consequently poly-ubiquitination and degradation
occur in the cytoplasm (171,172,173,174,175). Therefore, the finely tuned equilibrium between
FOXO3 transcription activities in the nuclear compartment and degradation in the cytosolic
compartment is maintained. However, pathophysiologic changes not only impair Akt/PKB
activity (reduced levels of pSer308 and pThr473 and enhanced Cys296S-nitrosylation as discussed
above), but also increase the activities of a number of stress kinases which phosphorylate
FOXO3 at sites different from those acted upon by IGF-1/insulin-IRS-PI3K-Akt. This results in
nuclear translocation and transactivation with modulation of FOXO3 activities by p300/CB-
mediated acteylation and Sirt1- mediated deacetylation [176,177,178,179,180].
Within thenucleus, FOXO3 binds to the target gene promoter; p300/CBP is recruited to the
DNA-FOXO3 complex and transcription of target proteins is stimulated; initially by acetylat‐
ing nucleosomal histones. Subsequently, there is p300/CBP mediated acetylation of FOXO3
which leads to dissociation from the promotor.At the same time, Sirt1 may stimulate or
maintain the binding of FOXO3 to DNA which stimulates deacetylation of acetylated FOXO3
under conditions of oxidative stress.FOXO3 may also be monoubiquitinated, which enhances
its transcriptional activity. Recent data has shown that nuclear Sirt1 deacetylation may render
the acetylated FOXO3 lysine residues (Lys242, Lys259, Lys290, Lys569 and possible Lys270, Lys271)
susceptible to polyubiquitination. Degradation of deacetylated FOXO3 appears to be mediated
by Skp2, a subunit of E3 ubiquitin ligase, which also binds to the Ser256 residue that is phos‐
phorylated by Akt/PKB. These regulatory pathways are illustrated in Figure 1. Therefore, the
hypothesis is that, burn injury stimulates muscle FOXO3 activities by altering an intricate
combination of phosphorylation, acetylation and ubiquitination,named “the FOXO3 code”
[181]. These PTMs are likely to occur concurrently and to affect each other, leading to burn
induced muscle wasting. Investigations of the complicated interlocking processes mediating
post translational modulations of regulatory proteins with a focus on nuclear protein FOXO3,
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in relation will lead to new knowledge about the mechanism(s) of muscle wasting after burn
injury. The effects of FOXO3 PTMs on its function have been studied extensively, but discrep‐
ant results have been reported by many investigators under different conditions. Unfortu‐
nately, little information about FOXO3 PTM in muscle after burn injury is currently available.
Determination of acetylation state of lysine residues in FOXO3 protein is dependent on
NanoLC-Q-TOF tandem mass spectrometry technology. Unlike labile phosphorylated or O-
GlcNac modified Ser residues, acetylated lysine residues are stable during tissue extraction
processes. The likelihood of false negative findings is minimal. Therefore, NanoLC-Q-TOF
tandem mass spectrometry provides accurate site-specific identification of acetylation on
lysine residue by detecting a mass shift (Δmass) of 42.01 Da [182]. In this project, we propose
to explore the relationship between FOXO3 acetylation and muscle wasting after burn injury.
Initially, quantitative real-time RT-PCR was performed to evaluate factors related to muscle
wasting at the mRNA level. IRS-1, SOCS3, Akt1, FOXO3, MAFbx, MuRF1, 14-3-3γ, Atg12,
Atg4a, Bnip3, and Gabarapl1 mRNA levels were measured as shown in Figure 20. In contrast
to the decrease in cellular IRS-1 protein levels, its mRNA expression was increased by 35%
Figure 20. Burn-induced proteasomal and lysosomal proteolysis gene expression in mouse skeletal muscle. Gene pro‐
files in sham treated (n=8) and burned mice; 3rd degree of 30% TBSA on day 7 after injury (n=15) indicate reduced
cytosolic FOXO3 degradation and enhancement in the proteasomal proteolysis pathway.
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(p<0.05). SOCS-3 and Akt1 mRNA expressions were also increased by 140% (p<0.005) and 110%
(p<0.05), respectively. Increased Akt1 mRNA expression was observed even though there were
decreased phosphorylations of Akt1 Ser473 and Thr308, and increased S-nitrosylation of
Cys296 in the kinase loop. These data suggest that impairment of the Akt mediated anabolic
pathway show an early tendency for transcriptional recovery on day 7 after injury. In contrast,
significant up-regulation of FOXO3 and no change in 14-3-3γ mRNA indicates that cytosolic
FOXO3 degradation via the 14-3-3γ complex continues to be reduced in responses to the burn
injury on day 7. Atg proteins, Binlp1, Gabarapl1 and many other proteins act together to
generate double-membrane autophagosomes, which transfer their contents to lysosomers.
However, all of these autophagy-related mRNAs were not significantly changed. In contrast,
increased atrogin-1/MAFbx and MuRF-1 mRNAs, although not significant on Day 7, suggest
that E3 ligase promoted proteasomal proteolysis is mainly responsible for muscle wasting after
burn injury, challenging the lysosome hypothesis [183,184].
The activity of FOXO3 is dependent on sub-cellular location which is regulated by a broad
range of PTMs: phosphorylation, acetylation and ubiquitination. Specifically, FOXO3 regula‐
tion mechanisms in association with nucleosomal histones are primarily controlled by
reversible acetylations as illustrated in Figure 1. Nineteen phosphorylated residues are listed
in the UniProtKB/Swiss-Prot and five acetylated sites in FOXO3 and seven sites in FOXO1 are
observed [185]. However, these data are not consistent between laboratories. For the first time,
two PTM isomers of muscle FOXO3 induced by burn injury were unambiguously confirmed
at the amino acid sequence level with the NanoLC-Q-TOF approach. As illustrated in Figure
22 (left panel) Western blot analysis confirmed the SDS-PAGE FOXO3 band splitting in skeletal
muscle of burned mice. The apparent SDS-PAGE MW of FOXO3 in skeletal muscle of sham
treated mice was ~87 kDa (672 AA, calc MW: 71,064) from varying amounts of FOXO3 in lanes
S30, S15 and S5. One extra band, located at apparent molwt of ~80 kDa as seen in lanes B30,
B15 and B5, was detected in skeletal muscle from burned mice. These two FOXO3 isomers
were clearly verified with recombinant human FOXO3 as shown in the right panel of Figure 21.
 
Figure 21. SDS-PAGE band splitting of FOXO3 Left panel:Immunoprecipitations of muscle lysates from burned and
sham treated mice were performed using anti-C-terminal antibody (sc-34895, 2 μg). The membrane was scanned over
near-infrared range. Right panel:Recombinant human FOXO3 was loaded onto the 12% Ready Gels with intact and
reduced goat IgG. Two FOXO3 bands were also found with molecular weights of above 87 and 80 kDa as compared
with intact IgG (150 kDa) and reduced IgG heavy chains (50 kDa).
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NanoLC-Q-TOF tandem mass spectrometry data revealed that burn-induced skeletal muscle
FOXO3 undergoing multiple phosphorylations and acetylations. These PTMs increase overall
FOXO3 negative charge which changes electrophoretic mobility during SDS-PAGE. Both
FOXO3 SDS-PAGE bands, obtained in vitro and in vivo, were unambiguously confirmed with
MS/MS sequencing. Criteria for positive skeletal muscle FOXO3 PTM identification were
defined as follows: 1. Tryptic peptides in digests must be unambiguously confirmed with MS/
MS sequencing with reference to protein data banks; 2. Both SDS-PAGE bands are verified as
FOXO3 isomers with at least two peptide sequence matches; 3. Mass accuracy of phosphory‐
lated and acetylated MS/MS ion shifts are: 79.97 ± 0.10 and 42.01 ± 0.10 Da; 4. S/N of phos‐
phorylated and acetylated MS/MS ions are >2. FOXO3 acetylated at the 241-Lys residue (~80
kDa) in mouse muscle after burn injury was sequenced as shown in Figure 22.
Our MS/MS data confirmed phosphorylation and acetylation in two domains of FOXO3, the
FOXO3 DNA binding domain and the FOXO3 transactivation/chromatin remodeling domain
as shown below:
FOXO3 DNA binding domain
Human FOXO3 tryptic peptide T4, triply charged
VLAPGGQDPGSGPATAAGGLSGGTQALLQPQQPLPPPQPGAAGGpS144GQPR
Burned mouse skeletal muscle FOXO3 tryptic peptide T18, doubly charged
SSWWIINPDGGACK241
FOXO3 transactivation/Chromatin remodeling domain
Human FOXO3 tryptic peptide T30-31, doubly charged
ACK271AALQTAPEpS280ADDpS284PSQLSACK290
In summary. Under physiological conditions, insulin induces FOXO3 phosphorylation in
muscle via IGF-1/insulin-IRS-PI3K-Akt, leading to the exclusion of FOXO3 from the nucleus
and binding to 14-3-3γ protein with subsequent poly-ubiquitination and degradation in the
cytoplasm. Similarly, acetylation of FOXO3 results in neutralization of the positive charges on
lysine residues and facilitates entry into the nuclear compartment. In the nucleus FOXO3 up-
regulates genes mediating skeletal muscle protein degradation and down-regulates genes
mediating skeletal muscle protein synthesis. The net result of the processes is muscle wasting.
In primitive man (i.e. “cave-man”) this was a highly adaptive process. For example when a
cave-man suffered from major trauma such as being “mauled by a saber tooth tiger” and
survived the insult to return to his cave, skeletal muscle wasting was critical for survival. Since
primitive man probably did not have significant amounts of adipose tissue and glycogen stores
provide limited substrates for energy production and anabolic function survival depended on
mobilization of skeletal muscle (in addition to some nutritional supplementation by friends
and relatives).
In modern society, after major trauma, the victim is usually confined to an intensive care unit
and nutritional metabolic requirements after injury are met by carefully controlled enteral and
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Figure 22. Site-specific pinpointing of acetylated Lys241 of FOXO3 in burned mouse muscle. Upper panel: Identifica‐
tion of mouse FOXO3 peptide T18 [M+2H]+2 = m/z 680.34, found: m/z 680.52. Lower panel: Zoom of the T18 peptide
y2 ion m/z 204.17 (241-Lys-Gly) and corresponding acetylated y2 ion m/z 246.12 (AC-241-Lys-Gly) indicates a mass
shift of 41.95 Da.
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parenteral nutrition. However the processes mediating FOXO3 entry in to the nucleus continue
to be manifest and muscle wasting persists leading to weakness and in severe cases respiratory
failure. Thus, a critical survival mechanism in primative man has transitioned to a major factor
in morbidity and mortality for victims of severe trauma and burns in today’s society.
5. Conclusion
PTM profiling of burn-induced IRS-1 C-terminal phosphorylation, S-nitrosylation of Akt1/
PKBα|| Cys296 and acetylation of FOXO3 Lys241, Lys271 and Lys290 expands our understanding
of insulin resistance and muscle wasting after burn injury. These findings reveal that Cys296-
Cys310 disulfide bond formation together with dephosphorylation of Thr308 in the kinase Akt1/
PKBα|| loop regulates FOXO3 sub-cellular distribution and transcriptional activity. The PTM
profiling enables new recognition patterns for partner’s molecules turn “on” and “off” of
enzyme activity and control the lifetime and location of the mediators in insulin signal
transduction [137,186]. IRS-1 integrity is reduced by 10% which is not a major factor in
downstreamsignaling. However, impaired Akt1/PKBa activity by 70% due to enhanced S-
nitrosylation of Cys296 and reduction of phosphor-Thr308 and Ser473 has major impact on FOXO3
sub-cellular distribution and activities. Muscle wasting but not insulin resistance is significant
in burned vs sham treated groups between days 3 and 7 post-burn injury. Our studies provide
a deep insight into the interrelationships between burn-induced oxidative and metabolic
stresses and muscle wasting in human patients [187].
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